ethambutol has been researched along with Koch's Disease in 675 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 274 (40.59) | 18.7374 |
1990's | 83 (12.30) | 18.2507 |
2000's | 95 (14.07) | 29.6817 |
2010's | 158 (23.41) | 24.3611 |
2020's | 65 (9.63) | 2.80 |
Authors | Studies |
---|---|
Hashizume, H; Kawasaki, M; Komatsu, M; Matsumoto, M; Sasaki, H; Shimokawa, Y; Tomishige, T; Tsubouchi, H | 1 |
Aarnoutse, RE; Boeree, MJ; Kibiki, GS; Kisanga, ER; van den Boogaard, J | 1 |
Perumal, S; Ranjith Kumar, R; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
Chen, S; Duan, W; Hu, Y; Luo, R; Wang, H; Yue, J; Zhang, X; Zhang, Y | 1 |
Bezerra, FA; Candéa, AL; Cardoso, LN; de Souza, MV; Ferreira, Mde L; Henriques, Md; Kaiser, CR; Lourenço, MC; Pais, KC | 1 |
Cardinot, D; Cunico, W; de Souza, MV; Ferreira, ML; Ferreira, TG; Gomes, CR; Lourenço, MC | 1 |
Kantevari, S; Sridhar, B; Sriram, D; Surineni, G; Yempala, T; Yogeeswari, P | 1 |
Chitra, S; Manisankar, P; Muthusubramanian, S; Paul, N; Sriram, D; Yogeeswari, P | 1 |
Bocanegra-García, V; García, A; Palma-Nicolás, JP; Rivera, G | 1 |
Constant, P; Daffé, M; Massimba Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
Barry, CE; Dartois, V | 1 |
Avupati, VR; Boddeda, B; Cheepurupalli, P; Gavalapu, VR; Killari, KN; Papasani, VM; Parala, VR; Yejella, RP | 1 |
Bifani, P; Camacho, LR; Chatterjee, AK; Diagana, TT; Dick, T; Goh, A; Herve, M; Jiricek, J; Kondreddi, RR; Kuhen, K; Lakshminarayana, SB; Ma, NL; Manjunatha, UH; Rao, R; Rao, SP; Smith, PW | 1 |
Kantevari, S; Sridevi, JP; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
Bogue, S; Cintra, G; Cole, ST; Crick, DC; Feng, X; Fontes, FL; Freitas-Junior, L; Gennis, RB; Gulati, A; Guo, RT; Jiang, T; Lechartier, B; Li, K; Li, Y; Liu, YL; Mitchell, DA; Molohon, K; No, JH; Oldfield, E; Orlean, P; Pujari, V; Rao, G; Ren, F; Schurig-Briccio, LA; Sun, H; Upadhyay, A; Yang, H; Zhu, W | 1 |
Devi, PB; Jeankumar, VU; Pedgaonkar, GS; Renuka, J; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 2 |
Boido, V; Cannas, S; Loddo, R; Molicotti, P; Novelli, F; Parapini, S; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Zanetti, S | 1 |
Chaturvedi, V; Dasgupta, A; Gupta, AD; Jaiswal, S; Kashyap, VK; Khan, SR; Krishnan, MY; Lal, J; Roy, KK; Saxena, AK; Sharma, A; Sharma, SK; Singh, S; Sinha, S; Srivastava, R | 1 |
Achur, R; Dalimba, U; Kumar, HS; Nayak, N; Peethambar, SK; Ramprasad, J; Sriram, D; Yogeeswari, P | 1 |
Constant, P; Daffé, M; Massimba-Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
Bhatt, JD; Chudasama, CJ; Patel, KD | 1 |
Corkran, HM; Dangerfield, EM; Haslett, GW; Stocker, BL; Timmer, MS | 1 |
Chakraborti, AK; Kumar, A; Sriram, D; Tanwar, B; Yogeeswari, P | 1 |
Mahajan, SS; Saharan, VD | 1 |
Feng, LS; Gao, C; Hu, YQ; Lv, ZS; Wu, X; Xu, Z; Zhang, S; Zhao, F | 1 |
Chang, L; Feng, LS; Gao, C; Lv, ZS; Ren, QC; Xu, Z; Zhang, S | 1 |
Feng, LS; Gao, C; Lv, ZS; Ren, QC; Song, XF; Xu, Z | 1 |
Barmade, MA; Chikhale, RV; Murumkar, PR; Yadav, MR | 1 |
Jachak, SM; Krishna, VS; Kumar, G; Sriram, D | 1 |
Baranyai, Z; Bősze, S; Janďourek, O; Krátký, M; Novotná, E; Stolaříková, J; Vinšová, J | 1 |
Cordeiro, R; Kachroo, M | 1 |
Dhawan, S; Girase, PS; Karpoormath, R; Kumar, V; Palkar, MB; Shinde, SR | 1 |
Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R | 1 |
Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
Bekker, A; Davies, G; Denti, P; Gonzalez-Martinez, C; Hesseling, AC; McIlleron, HM; Rabie, H; Svensson, EM; van der Laan, LE; van Rie, A; Wasmann, RE; Wiesner, L; Winckler, J; Zar, HJ | 1 |
Bollela, VR; Della Pasqua, O; Lanchote, VL; Nardotto, GHB; Rocha, A | 1 |
Bandere, D; Cirule, A; Grinberga, S; Igumnova, V; Kivrane, A; Krams, A; Pole, I; Pugovics, O; Ranka, R; Sevostjanovs, E; Viksna, A | 1 |
Maxwell, D; Patel, H; Sheikh, S; Skok, C | 1 |
Budiman, KY; Hidayat, B; Pratiwi, C; Santoso, P; Soekersi, H; Soeroto, AY | 1 |
Della Pasqua, O; Ferrer, S; Muliaditan, M; Ortega-Muro, F; Teutonico, D | 1 |
Aroulmoji, V; Bhuvaneswari, M; Deepa, M; Iqbal, MN; Khan, R; Saride, S; Sivasankar, C; Thirumalaisamy, R | 1 |
Anderson, R; Cholo, MC; Mashele, SA; Matjokotja, MT; Rasehlo, SSM; Steel, HC | 1 |
Jiang, H; Li, X; Niu, Q; Xing, Z; Xu, J | 1 |
Fus, M; Kyncl, M; Lestak, J | 1 |
Anderson, G; Vinnard, C | 1 |
Alshaer, MH; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kosek, M; Liu, J; Maro, A; Mduma, E; Mpagama, SG; Mujaga, B; Peloquin, CA; Rogawski McQuade, ET; Thomas, TA; Van Aartsen, D | 1 |
Al-Rabeai, DB; Khudhair, GS; Mohammed, KAS | 1 |
Bhargava, A; Das, AV; Kammari, P; Kurada, J; Sahoo, NK; Sheth, J; Shukla, S; Tyagi, M | 1 |
Abokadoum, MA; Boni, FG; Dai, Y; Ekomi Moure, UA; Hamdi, I; Moukendza Koundi, L; Shrestra, K; Suleiman, IM; Xie, J | 1 |
Alam, MDS; Cai, X; Chhotaray, C; Cook, GM; Fang, C; Gao, Y; Ge, H; Guo, L; Hameed, HMA; Lin, Y; Lu, Z; Maslov, DA; Peng, J; Tian, X; Wang, S; Yu, W; Yusuf, B; Zeng, S; Zhang, B; Zhang, G; Zhang, J; Zhang, T; Zhong, N | 1 |
George, S; Gerbo, RM; Hartman-Adams, H | 1 |
Jiang, Y; Li, J; Shen, X; Wang, L; Xu, B; Yu, C; Zhang, Y; Zheng, X | 1 |
Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N | 1 |
Cáceres-Pérez, AR; Fariña, JB; Oliva, A; Santoveña-Estévez, A; Suárez-González, J | 1 |
Al Moujahid, A; Bletsis, PP; de Jong, T; van den Elskamp, IJ; Wink, FR | 1 |
Kertys, M; Mokrý, J; Porvazník, I; Pršo, K; Solovič, I; Žideková, N | 1 |
Ali, MK; Mandal, A; Mane, SS; Pustake, M; Yadav, N | 1 |
Aboubakari, AS; Bombonne, M; Darré, T; Djiwa, T; Douaguibe, B; Kambote, Y; Sama, BM; Simgban, P; Tchaou, M | 1 |
He, W; Liu, D; Ou, X; Pei, S; Song, Z; Wang, S; Xia, H; Xing, R; Zhang, Z; Zhao, B; Zhao, Y | 1 |
Béranger, A; Gegia, M; Linh, NN; Mirzayev, F; Mohamed, A; Nahid, P; Radtke, K; Savic, RM; Schumacher, SG; Solans, BP | 1 |
Hatano, M; Igarashi, M; Kinoshita, N; Matsumoto, S; Matsunaga, S; Ozeki, Y; Samukawa, N; Tokudome, K; Tomita, S; Yamaguchi, T | 1 |
Anes, E; Duarte, ARC; Pires, D; Santos, F | 1 |
Ahn, S; Cho, YS; Hoa, PQ; Hung, TM; Jang, TW; Jayanti, RP; Kim, HJ; Kim, JS; Ko, Y; Lee, HY; Long, NP; Min, J; Mok, J; Oh, JY; Shin, JG | 1 |
Alves Pereira, VR; Carneiro Neves, MM; Correia de Sousa, LA; da Silva Santos, AC; de la Vega, J; Dos Santos Peixoto, A; Ferreira, LFGR; Hernandes, MZ; Linhares, LA; Lucena Laet, JP; Montenegro, LML; Olmo, ED; Pereira-Neves, A; San Feliciano, A; Schindler, HC | 1 |
Gadgil, CJ; Ramachandran, A | 1 |
Arriaga-García, FJ; Herrera-Pérez, IG; Medellín-Garibay, SE; Milán-Segovia, RDC; Ortiz-Álvarez, A; Rodríguez-Báez, AS; Rodríguez-Pinal, CJ; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
Ishikawa, K; Mori, N; Shibutani, K | 1 |
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
Aalhoul, F; Cotton, F; Fage, D | 1 |
Gonçalves, J; Marques, C; Nunes, C; Sarraguça, M | 1 |
Chaturvedi, V; Trivedi, P | 1 |
Dang, L; Lei, Q; Lv, X; Wang, H; Zhao, Y; Zhou, J; Zhu, C | 1 |
Heyckendorf, J; Kalsdorf, B; Lange, C; Maurer, FP | 1 |
Bai, H; Jiao, L; Liu, T; Lu, X; Lv, Y; Song, J; Wu, Q; Wu, T; Ying, B; Zhao, Z | 1 |
Chu, N; Guo, H; Lin, J; Liu, H; Liu, X; Wu, L; Ye, Z; Zheng, L | 1 |
Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G | 1 |
Guan, CX; Guo, Q; Jiang, Y; Li, GL; Li, MC; Liu, HC; Liu, ZG; Wan, KL; Wan, L; Wei, JH; Zhao, LL; Zhao, XQ | 1 |
Gao, R; Guo, Y; Shen, X; Tan, G; Wang, H; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Eller, P; Hackl, G; Hermann, J; Reisinger, AC; Vagena, FR | 1 |
Balakrishnan, S; Das, M; Manu, MS; Mehta, K; Neena, PS; Rakesh, PS; Satyanarayana, S; Sindhu, MP; Sunil Kumar, M; Valamparampil, MJ | 1 |
Desai, U; Doshi, K; Joshi, JM | 1 |
Xiao, K; Zhong, L | 1 |
Ceyhan, İ; Vezir, S | 1 |
Bitter, W; Commandeur, S; Iakobachvili, N; Mukamolova, GV; Nur, MM; Sparrius, M | 1 |
Chasweka, M; Chirambo, AP; Chitani, A; Davies, GR; Dilly-Penchala, S; Else, LJ; Gordon, SB; Khoo, SH; Malamba, RD; McCallum, AD; Meghji, JZ; Mwandumba, HC; Pertinez, HE; Sheha, I; Sloan, DJ | 1 |
Basol, G; Gonlugur, T; Gonlugur, U | 1 |
Anton, C; Bernardi, RM; Freitas, AA; Lemos, CX; Machado, FD; Silva, DR | 1 |
Bao, Z; Ge, W; Li, Q; Sha, X; Sheng, W; Su, L; Wu, S; Xu, Q; Zhu, L | 1 |
Einbeck, CO; Hunter, CJ; Yasukawa, K | 1 |
Gandhi, R; Garg, R; Karna, S; Lodha, R; Menon, V; Mohan, A; Phuljhele, S; Prakash, A; Saxena, R; Singh, D | 1 |
Alameer, R; Almaghrabi, RS; Almohaizeie, A; Alrajhi, AA; Alshehri, N; Nizami, I; Omrani, AS | 1 |
Andersson, DI; Bjarnemark, F; Brive, L; Glegola-Madejska, I; Godaly, G; Henderson, DI; Hjort, K; Krishnan, N; Millqvist Fureby, A; Puthia, M; Rao, KU; Robertson, BD; Sturegård, E; Tenland, E | 1 |
Chaudhary, S; Garg, V; Maji, S; Singh, V | 1 |
Bishai, W; Dawson, R; De Jager, V; Diacon, A; Donahue, K; Fletcher, CV; Hafner, R; Hogg, E; Miyahara, S; Sun, X; Swindells, S; Urbanowski, M | 1 |
Coban, AY | 1 |
Aarnoutse, R; Chabala, C; Chirehwa, M; Choo, L; Gibb, D; Hesseling, AC; Hissar, S; Kapasa, M; Kinikar, A; LeBeau, K; Mave, V; McIlleron, H; Mulenga, V; Palmer, M; Turkova, A; van der Zalm, M; Wiesner, L; Wobudeya, E; Zimba, KM | 1 |
Gleeson, F; Larson, A; Rajan, E | 1 |
Anupurba, S; Balgam, S; Fakir, NA; Gupta, A; Nema, V; Pal, SK; Pandey, D; Periera, M; Rathod, S; Sekar, G; Sinha, D; Sinha, P; SivaKumar, S; UmaDevi, KR | 1 |
Andres, S; Feuerriegel, S; Havlicek, J; Labugger, I; Merker, M; Niemann, S; Rivera-Milla, E; Slickers, P | 1 |
Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS | 1 |
Charfi, S; Ghorbel, A; Mnejja, M; Sellami, M | 1 |
Gunawan, R; Kartamihardja, AHS; Kurniawati, Y | 1 |
Baldin, VP; Campanerut-Sá, PAZ; Cardoso, RF; de Lima Scodro, RB; de Souza, EM; Evaristo, GPC; Fiorini, A; Ghiraldi-Lopes, LD; Meneguello, JE; Siqueira, VLD | 1 |
Deml, SM; Dionne, K; Martin, IW; Parrish, NM; Wengenack, NL | 1 |
Bian, Y; Cao, J; Huang, C; Liu, L; Mi, Y; Miao, L; Shi, C; Ye, Z | 1 |
Battini, S; Mannava, MKC; Nangia, A | 1 |
Adane, K; Dinant, GJ; Spigt, M | 1 |
Alvarez-Uria, G; Midde, M | 1 |
Gundert-Remy, U; Mielke, H; Partosch, F; Stahlmann, R | 1 |
Chen, W; Gao, S; Wang, Z; Xi, Y; Xie, X; Yang, Y; You, C | 1 |
Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Simonsson, USH; Svensson, RJ; Verbon, A | 1 |
Han, J; Lee, JY; Oh, SY; Park, KA; Seo, JG | 1 |
Al-Shaer, MH; Alghamdi, WA; Peloquin, CA | 1 |
Aarnoutse, RE; Aguirre, S; Alffenaar, JW; Chaparro, G; Coronel, R; Gomez, R; Gonzalez, F; Huisman, J; Jongedijk, E; Kerkhoff, J; Magis-Escurra, C; Martial, LC; Martinez, N; Molinas, G; Pérez, D; Rodríguez, M; Roman, M; Touw, DJ | 1 |
Das, A; Das, SK | 1 |
Aguilar-Pérez, C; Aínsa, JA; Brodin, P; Cebrián, R; Deboosère, N; Gracia, B; Maqueda, M; Rodrigues, L; Song, OR; Vitoria, A | 1 |
Abrahem, R; Cao, R; Gyurjian, K; Islamoglu, H; Munjal, S; Teskey, G; Venketaraman, V; Zhong, L | 1 |
Candéa, ALP; da Costa, MD; das Graças Muller de Oliveira Henriques, M; Helal-Neto, E; Nigro, F; Pereira, JX; Portilho, FL; Ricci-Junior, E; Rocha Pinto, S; Santos-Oliveira, R | 1 |
He, ZG; Hu, L; Liu, Y; Yang, M; Zhu, C | 1 |
Allix-Béguec, C; Arandjelovic, I; Beckert, P; Bi, L; Bonnet, M; Bradley, P; Cabibbe, AM; Cancino-Muñoz, I; Caulfield, MJ; Chaiprasert, A; Cirillo, DM; Clifton, DA; Comas, I; Crook, DW; De Filippo, MR; de Neeling, H; Diel, R; Drobniewski, FA; Faksri, K; Farhat, MR; Fleming, J; Fowler, P; Fowler, TA; Gao, Q; Gardy, J; Gascoyne-Binzi, D; Gibertoni-Cruz, AL; Gil-Brusola, A; Golubchik, T; Gonzalo, X; Grandjean, L; Guthrie, JL; He, G; Hoosdally, S; Hunt, M; Iqbal, Z; Ismail, N; Johnston, J; Khanzada, FM; Khor, CC; Kohl, TA; Kong, C; Lipworth, S; Liu, Q; Maphalala, G; Martinez, E; Mathys, V; Merker, M; Miotto, P; Mistry, N; Moore, DAJ; Murray, M; Niemann, S; Omar, SV; Ong, RT; Peto, TEA; Posey, JE; Prammananan, T; Pym, A; Rodrigues, C; Rodrigues, M; Rodwell, T; Rossolini, GM; Sánchez Padilla, E; Schito, M; Shen, X; Shendure, J; Sintchenko, V; Sloutsky, A; Smith, EG; Snyder, M; Soetaert, K; Starks, AM; Supply, P; Suriyapol, P; Tahseen, S; Tang, P; Teo, YY; Thuong, TNT; Thwaites, G; Tortoli, E; van Soolingen, D; Walker, AS; Walker, TM; Wilcox, M; Wilson, DJ; Wyllie, D; Yang, Y; Zhang, H; Zhao, Y; Zhu, B | 1 |
Augustino, D; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kibiki, GS; Kivuyo, S; Mduma, E; Mfinanga, S; Mmbaga, B; Nicodemu, I; Peloquin, CA; Thomas, TA; Yeconia, A; Zagurski, T | 1 |
Cunha, MCD; Mattos, FB; Pavan Taffner, BM; Saraiva, FP | 1 |
Akbal, AU; Albay, A; Aslan, G; Aslanturk, A; Bektore, B; Bicmen, C; Ceyhan, I; Coban, AY; Delialioglu, N; Ozkutuk, N; Ozyurt, M; Sertel Selale, D; Sig, AK; Surucuoglu, S; Ucarman, N; Uzun, M | 1 |
Chigutsa, E; Deshpande, D; Gumbo, T; Magombedze, G; McIlleron, H; Pasipanodya, JG; Srivastava, S; Visser, ME | 1 |
C Duarte, AR; P S Leitão, MI; Santos, F | 1 |
Ban, GY; Jeong, YJ; Kim, SH; Lee, SH; Park, HS; Shin, SS; Shin, YS; Ye, YM | 1 |
Anh, LTN; Anh, NT; Bestrashniy, J; Britton, WJ; Fox, GJ; Hoa, NB; Hoa, NLP; Jan, S; Lung, T; Marks, GB; Nhung, NV | 1 |
de la Guardia, M; Ezzati Nazhad Dolatabadi, J; Hamishehkar, H; Mesgari-Abbasi, M; Mohammadi, A; Mokhtarzadeh, A; Nemati, E; Panahi-Azar, V | 1 |
Ali, M; Mertaniasih, NM; Novita, BD; Pranoto, A; Soediono, EI | 1 |
Kabra, SK; Lodha, R; Mukherjee, A | 1 |
Bilgin, H; Tükenmez-Tigen, E | 1 |
Ahmed, S; Moore, DA; Nimmo, C; Nunn, AJ; Yates, TA | 1 |
Addo, MM; Galaski, J; Heinemann, M; Ittrich, H; Jordan, S; Mager, AK | 1 |
Choi, DG; Jin, KW; Lee, JY; Rhiu, S | 1 |
Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
Martins Dos Santos, VAP; Rienksma, RA; Schaap, PJ; Suarez-Diez, M | 1 |
Basso, EA; Gauze, GF; Kioshima, ÉS; Rodrigues, FA; Rozada, AM; Sampiron, EG; Scodro, RB; Seixas, FA | 1 |
Ali Aitbenasser, M; Benjelloun, A; Bouaity, B; Bouchentouf, R; Touati, M | 1 |
Braga, JU; da Conceição, DA; Trajman, A | 1 |
Buu, TN; Cobelens, FG; Dung, NH; Huyen, MN; Kremer, K; Lan, NT; Tiemersma, EW; van Soolingen, D | 1 |
Liu, P; Liu, Y; Ma, A; Wei, Q; Wu, X; Zhou, Z; Zou, F | 1 |
Benedetti, A; Law, S; Menzies, D; Oxlade, O; Schwartzman, K | 1 |
Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A | 1 |
Caleffi-Ferracioli, KR; Cardoso, RF; Maltempe, FG; Siqueira, VL | 1 |
Chen, TC; Chou, LT; Huang, CC; Lai, AB; Wang, JH | 1 |
Heysell, SK; Reynolds, J | 1 |
Pal, P; Patra, SK; Ray, S | 1 |
Bhattacharya, S; Choudhury, S; Das, A; Das, SK; Pandit, S | 1 |
Bock, N; Bozeman, L; Goldberg, SV; Hamilton, CD; Heilig, CM; Hershfield, E; Kyle, RP; Narita, M; Reves, R; Tapy, JM; Wing, D | 1 |
Chen, FC; Chen, YY; Dou, HY; Hsiung, CA; Huang, JM; Liao, YC; Lin, CH | 1 |
Anupurba, S; Gupta, A; Kulkarni, S; Rastogi, N | 1 |
Chigutsa, E; Gumbo, T; McIlleron, H; Pasipanodya, JG; Sirgel, FA; Smith, PJ; van Helden, PD; Visser, ME | 1 |
Bhatnagar, S; Faurholt-Jepsen, D; Friis, H; Grewal, HM; Kabra, SK; Lodha, R; Mukherjee, A; Saini, S; Singh, S; Singh, V | 1 |
Alobu, I; Oshi, DC; Oshi, SN; Ukwaja, KN | 1 |
Aleo, A; Bonura, C; Fasciana, T; Giammanco, A; Gomgnimbou, MK; Mammina, C; Refrégier, G; Sola, C | 1 |
Ahmad, MI; Nakpheng, T; Srichana, T | 1 |
Jiang, Y; Li, GL; Liu, HC; Sun, Q; Wan, KL; Wu, XC; Xiao, TY; Zeng, CY; Zhao, LL; Zhao, XQ | 1 |
Hershow, RC; Huo, D; Jimenez, A; Johnson, W; Paul, W; Prachand, N; Rahimian, A; Ricks, PM; Wiebel, W | 1 |
de Lauzanne, A; Faye, A; Koehl, B; Levy, M; Lorrot, M; Melki, I; Rigaudière, F | 1 |
Lipman, MC; Phillips, PP | 1 |
Reves, RR | 1 |
Chakraborty, S; Rhee, KY | 1 |
Acuña-Villaorduña, C; Ayakaka, I; Dryden-Peterson, S; Fennelly, KP; Hosford, J; Jones-López, EC; Nakubulwa, S; Okwera, A; Reilly, N; Worodria, W | 1 |
Aprile, V; Centis, R; Costa, D; D'Ambrosio, L; Donateo, L; Fedele, A; Gillini, L; Migliori, GB; Pasanisi, G; Tundo, P | 1 |
Achinelli, FR; Ferreyra, FG; Golemba, AS; Martearena, RE; Rovai, GB | 1 |
Anandkumar, A; Balasubramanian, V; Datta, S; Karmarkar, M; Khandelwal, S; Kumar, N; Nanduri, R; Narayanan, S; Panduga, V; Prabhakar, KR; Rajagopalan, S; Ramachandran, V; Rao, N; Reddy, J; Saralaya, R; Shandil, R; Sharma, S; Singh, R; Solapure, S | 1 |
Izzatun, N; K, S; Lisdawati, V; M, M; Parwati, I; Puspandari, N; Ratnasari, L; Rif'ati, L; Soekarno, T | 1 |
Huang, H; Jia, H; Sun, Z; Xu, Y; Zhang, Z | 1 |
Ciesek, S; Hoeper, MM; Kielstein, JT; Kühn, C; Schmidt, JJ; Strunk, AK; Welte, T | 1 |
Gie, RP; Graham, SM; Grzemska, M | 1 |
Allegra, S; Baietto, L; Bonora, S; Calcagno, A; Cusato, J; D'Avolio, A; Fatiguso, G; Favata, F; Motta, I; Perri, GD | 1 |
Hwang, JM; Lee, CT; Lee, JH; Park, JS; Park, MJ; Yang, HK | 1 |
Gotoh, H; Kurasima, A; Matsuda, S; Morimoto, K; Ogata, H; Okumura, M; Osawa, T; Sasaki, Y; Yanai, H; Yoshiyama, T | 1 |
Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
Barbosa, AR; Caleffi-Ferracioli, KR; Cardoso, RF; García-Ramos, JC; Leite, CQ; Pavan, FR; Ruiz-Azuara, L; Siqueira, VL; Toledano-Magaña, Y | 1 |
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T | 1 |
Feizabadi, MM; Haeili, M; Hashemi Shahraki, A; Imani Fooladi, AA; Mohajeri, P; Rezaei, F; Zahednamazi, F | 1 |
Al-Efraij, K; Campbell, JR; Cook, VJ; Johnston, J; Marra, F; Mota, L | 1 |
Hamilton, CD; Holland, DP; Stout, JE | 1 |
Choi, JH; Heo, NY; Jo, KM; Kim, WG; Nam, KH; Park, CS; Park, SH | 1 |
Günther, G; Hunter, C; Kibuule, D; Rennie, TW; Verbeeck, RK | 1 |
Baker, B; Chibale, K; Chouteau, F; de Kock, C; Macingwana, L; Madikane, E; Mmutlane, EM; Ngwane, AH; Panayides, JL; Parkinson, CJ; van Helden, P; Viljoen, A; Wiesner, L; Wiid, I | 1 |
Jiao, WW; Shen, AD; Wang, T | 1 |
Asres, A; Deressa, W; Jerene, D | 1 |
Bright-Thomas, RJ; Gondker, AR; Morris, J; Ormerod, LP | 1 |
Bartoletti, M; Bertuzzo, V; Cristini, F; Giannella, M; Lewis, RE; Martelli, G; Morelli, M; Pianta, P; Pinna, AD; Tadolini, M; Tedeschi, S; Viale, P | 1 |
Chida, K; Fujita, K; Hayakawa, H; Miwa, S; Murakami, M; Nakamura, H; Ohba, H; Shirai, M; Suda, T; Suzuki, Y | 1 |
Adhvaryu, MR; Reddy, N; Vakharia, BC | 1 |
Inge, LD; Wilson, JW | 1 |
Grzemska, M; Hill, S; Matiru, R; Regondi, I | 1 |
Borgdorff, MW; He, GX; Jiang, GL; Liu, YH; van den Hof, S; van der Werf, MJ; Wang, LX; Wang, SF; Xia, H; Zhao, YL | 1 |
Brum, L; Macedo, R; Perdigão, J; Portugal, I; Ribeiro, A | 1 |
Chauhan, DS; Das, R; Jadaun, GP; Katoch, VM; Sharma, VD; Upadhyay, P | 1 |
Ahmad, S; Jaber, AA; Mokaddas, E | 1 |
Belknap, R; Kestler, M; Reves, R | 1 |
Azeeza, S; Kamal, A; Malik, MS; Rao, MV; Shaik, AA | 1 |
Albrethsen, J; Balasubramanian, V; Balganesh, T; Belanova, M; Bharath, S; Bobovska, A; Brodin, P; Brosch, R; Buroni, S; Butcher, P; Christophe, T; Cole, ST; De Rossi, E; Dhar, N; Dianiskova, P; Fullam, E; Gaonkar, S; Grosset, J; Kordulakova, J; Lucarelli, AP; Makarov, V; Manina, G; McKinney, JD; Mikusova, K; Milano, A; Möllmann, U; Nandi, V; Pasca, MR; Riccardi, G; Rosenkrands, I; Ryabova, O; Saint-Joanis, B; Sala, C; Schneider, P; Shandil, RK; Tyagi, S; Waddell, S | 1 |
Alves-Filho, G; Bignotto Rosane, D; Guida, JP; Mazzali, M; Ribeiro Resende, M; Urbini-Santos, C | 1 |
Chen, YC; Ho, CC; Hu, FC; Luh, KT; Yang, PC; Yu, CJ | 1 |
Basir, Y; Chu, D; Gong, Z; McCort-Tipton, M | 1 |
Angeby, KA; Chryssanthou, E; Giske, CG; Hoffner, SE; Juréen, P; Kahlmeter, G; Schön, T; Sturegård, E; Werngren, J | 1 |
Hanna, LE; Narayanan, PR; Nayak, K; Subramanyam, S; Swaminathan, S; Venkatesan, P | 1 |
Akrim, M; Chaoui, I; El Mzibri, M; Elouad, R; Jordaan, AM; Kourout, M; Lahlou, O; Sabouni, R; Victor, TC | 1 |
Cox, HS; Doshetov, D; Kalon, S; Niemann, S; Plinke, C; Rüsch-Gerdes, S | 1 |
Chinnaiyan, P; Iliayas, S; Menon, PA; Narayanan, PR; Narendran, G; Padmapriyadarsini, C; Ramachandran, R; Sakthivel, R; Santhanakrishnan, R; Suhadev, M; Swaminathan, S; Venkatesan, P | 1 |
Baraka, A; Cobelens, F; Egwaga, S; Grewal, P; Haag-Arbenz, V; Lwilla, F; Mkopi, A; Mshinda, H; Range, N; van Leth, F | 1 |
Deng, X; Fan, J; Ge, F; Guo, N; Jin, Q; Liu, S; Song, Y; Wang, X; Wu, X; Ye, H; Yu, L; Zeng, F | 1 |
Gumbo, T | 1 |
Baseke, J; Boom, WH; Charlebois, E; Chervenak, KA; Havlir, DV; Johnson, DF; Lancioni, C; Mahan, CS; Mayanja-Kizza, H; Mugerwa, RD; Walusimbi, M; Whalen, CC | 1 |
Bessong, PO; de Villiers, BE; Green, E; Hoosen, AA; Letsoalo, T; Nchabeleng, M; Ndip, RN; Obi, CL; Sein, PP | 1 |
Cansü, E; Erdogan, F; Ulusam, AO | 1 |
Başustaoğlu, AC; Ceyhan, I; Güllü, U; Kiliç, A; Kiliç, S; Simşek, H; Tarhan, G; Uçar, E; Yilmaz, S | 1 |
Chen, YH; Hsu, HJ; Lee, MF; Peng, CF | 1 |
Aloui, N; Bousnina, S; Boussetta, K; Brini, I; Ghaffari, H; Jaubert, F; Tinsa, F | 1 |
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A | 1 |
Burman, W; Duran, P; Engle, M; Goldberg, S; Johnson, JL; Mugerwa, RD; Muzanye, G; Padayatchi, N; Prihoda, TJ; Sturm, AW; Weiner, M | 1 |
Camara, P; Chevalier, B; Debonne, JM; Fabre, M; Gueye, M; Herve, V; Lefebvre, N; Margery, J; Mbaye, PS; Perrier-Gros-Claude, JD; Sane, M; Simon, F; Soler, C; Thiam, M | 1 |
Aydın, F; Bayramoğlu, G; Buruk, K; Dede, R; Dinç, U; Kaklıkkaya, N; Köse, T; Ozkul, G | 1 |
Bello, T; Chirinos, G; De Donato, M; de Waard, JH; Mendoza, R; Takiff, H | 1 |
Abes, FL; Abes, GT; Jamir, JC | 1 |
Hossain, A; Hossain, M; Islam, S; Khalil, I; Mottalib, A | 1 |
da Silva Junior, GB; Daher, Ede F; de Oliveira, JL | 1 |
Davidse, A; Jönsson, S; Karlsson, MO; McIlleron, H; Simonsson, US; Smith, P; Van der Walt, JS; Wilkins, J | 1 |
Kuwabara, K | 1 |
Eide, GE; Kielland, LG; Naess, A; Sørnes, S; Vage, RA | 1 |
Bonkoungou, V; Carvalho, AC; Comelli, M; Cusato, M; Dembélé, SM; Kouanda, S; Matteelli, A; Nacanabo, R; Regazzi, M; Saleri, N; Villani, P | 1 |
Ausina, V; Domínguez, J; García-Sierra, N; Gavin, P; Haba, L; Lacoma, A; Maldonado, J; Prat, C; Ruiz-Manzano, J; Samper, S | 1 |
Adhikari, P; Kandel, H; Ruokonen, EL; Shah, DN; Shrestha, GS | 1 |
Aarnoutse, R; Boeree, M; Ijdema, D; Magis-Escurra, C; van den Boogaard, J | 1 |
Adali, G; Çolak, Y; Enç, F; Kiziltaş, Ş; Öztürk, O; Tuncer, İ; Ulaşoğlu, C; Yorulmaz, E | 1 |
Beer, J; Emmrich, F; Rodloff, AC; Sack, U; Tessema, B | 1 |
Accinelli, RA; Agapito, JC; Bañuls, AL; Espinoza, JR; Godreuil, S; Goodman, SJ; Shaw, MA; Taype, CA | 1 |
Friedrich, C; Grundmann, K | 1 |
Cohen, T; Furin, J; Gegia, M; Kalandadze, I; Vashakidze, L | 1 |
Freedberg, KA; Kumarasamy, N; Losina, E; Mayer, KH; Pho, MT; Ponnuraja, C; Scott, CA; Swaminathan, S; Uhler, LM; Walensky, RP | 1 |
Peña-Santos, G; Ruiz-Moreno, JL | 1 |
Chen, HY; Chen, PC; Lai, SW; Muo, CH; Wang, IJ | 1 |
Aarnoutse, RE; de Groot, R; de Waard, JH; García, JF; Hermans, PW; López, D; Verhagen, LM; Warris, A | 1 |
Böttger, EC; Sirgel, FA; Streicher, EM; van Helden, PD; Victor, TC; Warren, RM | 1 |
Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G | 1 |
Lu, J; Pang, Y; Song, Y; Wang, S; Wang, Y; Zhao, Y | 1 |
Chandrasekaran, P; Chinnaiyan, P; Elangovan, T; Gopalan, N; Iliayas, S; Menon, PA; Navaneethapandian, PD; Paranji Ramaiyengar, N; Perumal, V; Pho, MT; Ramachandran, R; Santhanakrishnan, RK; Swaminathan, S; Wares, F | 1 |
Lueangniyomkul, A; Mankatitham, W; Manosuthi, S; Manosuthi, W; Nilkamhang, S; Sukasem, C; Sungkanuparph, S; Thongyen, S | 1 |
Kim, KJ; Nam, JS; Ro, YT; Yoon, JH | 1 |
Benedetti, A; Darvish-Zargar, M; Ezer, N; Menzies, D | 1 |
Bambery, P; Bhatnagar, A; Khullar, M; Singh, S; Sud, A; Wanchu, A | 1 |
Agrawal, S; Bhade, SR; Kaul, CL; Kaur, KJ; Panchagnula, R; Singh, I | 1 |
George, I; Gross, W; Lipman, H; Madison, B; Mazurek, G; Metchock, B; Ridderhof, J; Robinson-Dunn, B; Sloutsky, A; Washabaugh, G | 1 |
Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA | 1 |
Bonnaud, F; Zigani, A | 1 |
Dekker, TG; Lötter, AP | 1 |
Danckwerts, MP; Ebrahim, S; Pillay, V | 1 |
Mohan, B; Singh, S | 1 |
Boelaert, RJ; Grosset, J; Lounis, N; Maslo, C; Truffot-Pernot, C | 1 |
Fodor, T; Mester, J; Vadász, I | 1 |
LAL, HM; ROBSON, JM | 1 |
DELAUDE, A; JORDA, MF; MOREAU, G | 1 |
KANAI, K; MUROHASHI, T; NAKAMURA, R | 1 |
MORIYAMA, E | 2 |
CHAVES, AD | 1 |
SUTINEN, S; TUOVINEN, PI | 1 |
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
BUYSKE, DA; PEETS, EA; PLACE, VA; SWEENEY, WM | 1 |
KONNO, K; KUDO, S; MUNAKATA, K; OIZUMI, K; OKA, S; YAMAGUCHI, S | 1 |
KASS, I | 1 |
Ahmad, RN; Anwar, M; Butt, T; Karamat, KA; Kazmi, SY; Mahmood, A | 1 |
Kosmorsky, GS; Lee, MS; Melamud, A | 1 |
Anagnostou, S; Costopoulos, C; Gitti, Z; Kontos, F; Maniati, M; Maniatis, AN; Nicolaou, S; Petinaki, E; Tselentis, I | 1 |
Schuh, A; Zeiler, G | 1 |
Hamada, H; Hamada, M; Hara, Y; Higaki, J; Katayama, H; Ogimoto, A; Saeki, H; Shigematsu, Y | 1 |
Asencios-Solis, L; Bayona, J; Becerra, MC; Leo-Hurtado, E; Quispe-Torres, N; Salazar-Lindo, E; Vásquez-Campos, L | 1 |
Avkan Oğuz, V; Cakmak, R; Erkut, M; Güneri, S; Ozgü, A; Oztop, A; Unsal, I | 1 |
Bhagavathy, S; Gurumurthy, P; Hemanth Kumar, AK; Mahilmaran, A; Padmapriyadarsini, C; Paramesh, P; Rajasekaran, S; Ramachandran, G; Ravichandran, N; Sekar, L; Swaminathan, S; Venkatesan, P | 1 |
Baumanis, V; Jansone, I; Marga, O; Nodieva, A; Skenders, G; Tracevska, T | 1 |
Coward, L; Gorman, G; Hanrahan, C; Jia, L; Nikonenko, B; Noker, P; Protopopova, M; Tomaszewski, JE | 1 |
Callister, SM; DeCoster, DJ; Schell, RF; Vena, RM | 1 |
Fattorini, L; Isola, D; Meacci, F; Niemann, S; Orefici, G; Orrù, G; Pardini, M; Rinaldo Oggioni, M; Rüsch-Gerdes, S; Trappetti, C; Varaine, F | 1 |
Bhatia, A; Goyal, JL; Singh, NP | 1 |
Ashokraj, Y; Bhade, SR; Kaul, CL; Kaur, KJ; Kohli, G; Panchagnula, R; Singh, I; Varma, MV | 1 |
Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
Chen, P; Einck, L; Gearhart, J; Hanrahan, C; Nacy, CA; Nikonenko, B; Protopopova, M; Samala, R | 1 |
Curry, K; Yoon, Y | 1 |
Abed, MS; Al-Muraikhy, AA; Al-Tawfiq, JA | 1 |
Du, C; Otomo, K; Shi, R; Sugawara, I; Wang, G; Yamada, H; Zhang, G | 1 |
Bell, DJ; Graham, SM; Hartkoorn, R; Molyneux, EM; Nyirongo, S; Ward, SA | 1 |
Dosso, M; Kamate, M; N'Guessan, K; Nahoua, G; Vincent, V | 1 |
Aggarwal, N; Aggarwaln, JK; Dhingra, VK; Jain, SK; Rajpal, S; Shadab, K | 1 |
Alrajhi, AA | 1 |
Burger, A; Folb, PI; McIlleron, H; Norman, J; Smith, P; Wash, P | 1 |
Lim, SA | 1 |
He, Z; Song, H; Sun, J; Wang, Z; Zhang, T | 1 |
Ecder, T; Erelel, M; Kocabay, G; Tutkun, IT | 1 |
Baquero-Artigao, F; Del Castillo, F; García-Miguel, MJ; Méndez-Echevarría, A; Pascual, SI; Velázquez, R | 1 |
Back, DJ; Bertel Squire, S; Chandler, B; Hartkoorn, RC; Khoo, SH; Owen, A; Ward, SA | 1 |
Aydin, O; Bakir Ozbey, S; Helvaci, S; Kasapoğlu, F | 1 |
Detjen, A; Magdorf, K; Quarcoo, D; Thee, S; Wahn, U | 1 |
Kwon, SY; Lee, CT; Lee, JH; Lee, SW; Park, KU; Song, J; Um, SW; Yoon, HI | 1 |
Bakker-Woudenberg, IA; de Steenwinkel, JE; Schiffelers, RM; Ten Kate, MT; van Agtmael, MA; van Vianen, W; Verbrugh, HA | 1 |
Otomo, K; Shi, R; Sugawara, I; Zhang, G; Zhang, J | 1 |
Bant, A; Markov, M; Nadir, A; Patel, K; Raeesy, A; Van Thiel, DH | 1 |
Hattori, T; Koyama, A; Mitarai, S; Otomo, K; Sato, A; Seki, M; Shishido, Y; Yano, I | 1 |
Shirasaka, T | 1 |
Agrawal, D; DiMase, JD | 1 |
Freerksen, E | 3 |
Brock, PG; Roach, M | 1 |
Burghard, G; Cooreman, J; Grosset, J | 1 |
Nagami, P; Yoshikawa, TT | 1 |
Agzamov, RA; Arifkhanova, SI; Ginzburg, VS | 1 |
Hetrick, G; Humarau, H | 1 |
Jones, FL | 1 |
Dutt, AK; Stead, WW | 1 |
Durr, FE; Thomas, JP | 1 |
Van Scoy, RE; Wilkowske, CJ | 2 |
Broquié, G | 2 |
Djurisić, M; Jovanović, M; Vlahović, M | 1 |
Engbaek, HC; Heckscher, T; Højgaard, C; Larsen, SO; Rasmussen, KN; Vergmann, B | 1 |
Halevy, J; Pitlik, SD; Rabinovitz, M; Rosenfeld, JB | 1 |
Bonifazi, F; Gasparini, S; Sanguinetti, CM | 1 |
Nagami, PH; Yoshikawa, TT | 1 |
Back, DJ; Breckenridge, AM; Crawford, FE; Hall, JM; MacIver, M; Orme, ML; Rowe, PH; Smith, E; Watts, MJ | 1 |
Nuding, K | 1 |
Diktaban, T; Lucente, FE | 1 |
Jain, VK; Mathur, KC | 1 |
Andrew, OT; Hopewell, PC; Humphreys, MH; Schoenfeld, PY | 1 |
Iseman, MD | 1 |
Barfield, C; Masi, AT | 1 |
Wall, MA | 1 |
Düren, M; Durgun, V; Göksoy, E; Uygun, N | 1 |
Casal, M; de la Mata, M; Gutierrez Aroca, J; Miño, G; Pera, C; Rufian, S; Torre-Cisneros, J; Villanueva Marcos, JL | 1 |
Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
Chum, HJ; Enarson, DA; Ilmolelian, G; Ipuge, YA; Msangi, J; Mwinyi, N; Rieder, HL; Zwahlen, M | 1 |
Gninafon, M; Lambregts-van Weezenbeek, CS; Tawo, L; Trebucq, A | 1 |
Groenewald, P; Lombard, CJ; Weyer, K; Zwarenstein, M | 1 |
Batchelor, B; Brindle, R; Gathua, S; Gilks, C; Githui, W; Godfrey-Faussett, P; Hawken, M; Morris, J; Nunn, P; Odhiambo, J | 1 |
Bohmer, PD; Macnab, MF; Seager, JR | 1 |
Farrer, J; Furney, SK; Orme, IM; Skinner, PS | 1 |
Macnab, MF; Seager, JR | 1 |
Anglaret, X; Lacassin, F; Leport, C; Longuet, P; Perronne, C; Saba, J; Vildé, JL | 1 |
Bermudez, LE; Inderlied, CB; Kolonoski, P; Young, LS | 1 |
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
Aleksandrova, AE; Tschegoleva, RA; Vinogradova, TI | 1 |
Altman, C; Biour, M; Grangé, JD | 1 |
Dickinson, JM; Guy, A; Mitchison, DA | 1 |
Denison, AV; Pierce, JR | 1 |
Jezierska-Anczuków, A; Zalewska-Schöntaler, N | 1 |
Bergmann, F; Fehrenbach, J; Jautzke, G; Mauch, H; Ruf, B; Schürmann, D | 1 |
Chugh, KS; Jha, V; Joshi, K; Sakhuja, V; Varma, PP | 1 |
Fahn, HJ; Hsu, HS; Huang, MH; Wang, LS; Wu, YC | 1 |
Aguilar, X; Fernández-Muixí, J; Gallego, M; Morera, J; Ribas, J; Richart, C; Ruiz, J; Teixidó, A | 1 |
Brook, MG; Miller, RF | 1 |
Matthews, TJ; Peto, RJ | 1 |
Barry, P; Isselin, J; Regnard, PJ | 1 |
Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 2 |
Bermudez, LE; Kolonoski, P; Young, LS | 1 |
Begić-Janeva, A; Boricić, I; Brmbolić, BJ; Jevtović, DL; Ranin, JT; Salemović, DR | 1 |
Belt, EL; Durrheim, DN | 1 |
Egawa, H; Inomata, Y; Kiuchi, T; Okajima, H; Sano, K; Satomura, K; Tanaka, K; Uemoto, S; Uyama, S; Yamaoka, Y | 1 |
Alvarez, L; Diliz, HS; Hernandez, A; Treviño, M; Zaragoza, RM | 1 |
Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE | 1 |
Barry, CE | 1 |
Elcock, M; Kent, JH; Maxwell, R; Meador, J; Onorato, I; Ridzon, R; Royce, S; Shefer, A; Smith, P; Valway, S; Weismuller, P; Woodley, C | 1 |
Trébucq, A | 1 |
Cook, MB; Degnan, MT; Ferguson, RM; Franzblau, SG; Gilman, RH; Hernandez, A; Madico, G; McLaughlin, JC; Quenzer, VK; Torres, P; Witzig, RS | 1 |
Dautzenberg, B; Jouveshomme, S | 1 |
Clumeck, N; De Wit, S; Payen, MC | 1 |
Ali, SA; Amanullah, S; Arif, K; Khan, JA; Nayani, P; Siddiqui, I | 1 |
Binkin, N; Bustreo, F; Chaulet, P; Cohn, DL; Kim, SJ; Lambregts-van Weezenbeek, CS; Laszlo, A; Nunn, P; Pablos-Méndez, A; Raviglione, MC; Rieder, HL | 1 |
Chenevier, P; Farinotti, R; Gueylard, D; Massias, L | 1 |
Ivanyi, J; Moreno, C; Pasvol, G; Sjölund, A; Vordermeier, HM; Wilkinson, KA; Wilkinson, RJ | 1 |
Dass, A; Goyal, A; Mohan, H; Nagarkar, NM; Uppal, KS | 1 |
Bao, O; Diouf, B; Diouf, ML; Ka, MM; Mbengue, M; Moreira-Diop, T; Niang, A; Pouye, A | 1 |
Banerjee, A; Daley, HM; Graham, SM; Harries, AD; Salaniponi, FM | 1 |
Duan, L; Li, H; Liang, G | 1 |
Connolly, C; Davies, GR; McAdam, KP; Sturm, AW; Wilkinson, D | 1 |
Alwood, K; Bishai, WR; Blazes, D; Chaisson, RE; Coggin, W; Gachuhi, R; Sterling, TR | 1 |
Drobniewski, FA; Eltringham, IJ; Wilson, SM | 1 |
Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Thoresen, OF; Xiao, Y | 1 |
Haberal, M; Kalpaklioglu, AF; Moray, G; Oner-Eyüboglu, AF | 1 |
Emre, S; Meyers, BR; Miller, C; Papanicolaou, GA; Sheiner, P | 1 |
Fonquernie, L; Frottier, J; Kirstetter, M; Le Van, JC; Meynard, JL; Meyohas, MC; Prévot, S | 1 |
Daniel, N; Geiter, LJ; Grosset, J; Hejblum, G; Ji, B; Lounis, N; O'Brien, RJ; Szpytma, M; Truffot-Pernot, C; Vernon, A | 1 |
Jasmer, RM; Small, PM | 1 |
Chagaluka, S; Drobniewski, F; Fine, PE; Glynn, JR; Jenkins, PA; Ngwira, B; Pönnighaus, JM; Warndorff, DK; Yates, M | 1 |
Barros, V; Bosne-David, S; David, HL; Portugal, C; Verde, SC | 1 |
Chase, SE; Cynamon, MH; Lenaerts, AM | 1 |
Choi, IS; Huh, WS; Joh, JW; Kim, MK; Kim, SJ; Kim, SM; Ko, YH; Lee, BB; Lee, SK; Oh, HY; Park, JB; Peck, KR; Song, JH | 1 |
Gupta, HP; Gupta, R; Rathi, GL; Sharma, AK; Tolani, SL | 1 |
Kaur, D; Khuller, GK | 1 |
Barry, CE; Lee, R; Schoolnik, GK; Wilson, M | 1 |
Khan, MY; Kinsara, AJ; Memish, Z; Osoba, AO; Samman, Y; Wali, S | 1 |
Bowersox, J | 1 |
Appelberg, R; Gonçalves, AS | 1 |
Ellard, GA; Fourie, PB; Pillai, G; Smith, PJ | 1 |
Banerjee, A; Harries, AD; Kok, GJ; Manders, AJ; Salaniponi, FM; van den Borne, HW | 1 |
Long, R; Ollé-Goig, J; Scalcini, M | 1 |
Hira, SK; Kura, MM | 1 |
Chen, L; Liang, Y | 1 |
Liang, Y | 1 |
Spedini, P | 1 |
Ding, D; Duanmu, HJ; Li, D; Peng, YL; Song, H; Wang, G; Wang, L; Xing, J; Zhang, G; Zhang, L; Zhang, Z | 1 |
Isla, AM; Riaz, AA; Robshaw, P; Singh, A | 1 |
Petrenko, VM; Shkol'nyĭ, LK | 1 |
Martin, PD | 1 |
Bates, JH | 1 |
Newton, RW | 1 |
Springett, VH | 1 |
Clarke, PD | 1 |
Nair, NG; Radhakrishna, S; Subbammal, S; Tripathy, SP | 1 |
Harris, AA; Karakusis, P | 1 |
Vieritz, HD | 1 |
Duroux, P | 1 |
van Geuns, HA | 1 |
Kuntz, HD; Rausch, V | 1 |
Ashkar, B; Bishop, M; Cleary, MG; Schiffman, PL | 1 |
Anastasatu, C; Plopeanu, D | 1 |
Lebeau, B; Rochemaure, J | 1 |
Bailey, WC; Maetz, HM; Sellers, CA; Sheehy, TW; Sutton, FD | 1 |
Brown, RC | 1 |
Seaton, A | 1 |
Darbyshire, JH; Friedmann, AI; Kun, OJ; Pattisson, PR; Tall, R | 1 |
Kanai, K; Kondo, E | 2 |
Jaworski, J; Klasińska, N; Ziobrowski, S | 1 |
Prachakvej, P; Subharngkasen, I | 1 |
Ciechanowska, A; Gergovich, A | 1 |
Abbate, E; Gini, G; González Montaner, LJ; Palma Beltran, O | 1 |
Aujard, Y; Beaufils, F; Caron, M; Choulot, JJ; Labrune, B | 1 |
McNicol, M | 1 |
Koerner, SK; Pinsker, KL | 1 |
Dickinson, JM; Mitchison, DA | 3 |
MacGregor, RR; Mayock, RL | 1 |
Korotaev, GA; Kozulitsyna, TI; Uvarova, OA | 1 |
Rosenzweig, DY | 1 |
Frey, N; Legrand, M; Peltier, G; Teyssier, L | 1 |
Albengres, E; Breau, JL; Chrétien, J; Hirsch, A; Houin, G; Saltiel, JC; Tillement, JP | 1 |
Van Scoy, RE | 1 |
McConville, JH; Rapoport, MI | 1 |
Kozma, D; Lapis, K; Tompa, A | 1 |
Giunta, J; Maloney, PL; Turbiner, S | 1 |
Tala, E | 1 |
Haegi, V | 1 |
Trusiewicz, D | 1 |
Derka, H | 1 |
McClement, JH | 1 |
Hoose, C | 1 |
Vale, JR | 1 |
Jentgens, H | 2 |
Krchnavá, B; Slámová, J | 1 |
Bourquin, C; Korol, S | 2 |
Kumar, L | 1 |
Cohen, Y; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vildé, JL | 1 |
Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
Kahana, LM | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
Nolan, CM | 1 |
Kikuchi, Y; Kimura, S; Mitamura, K; Oka, S; Shimada, K | 1 |
Ahmad, W; Aziz, S; Jamal, Q; Qureshi, H; Zuberi, SJ | 1 |
Blanc, JM; de Francisco, JE; Fumanal, L; Garcia Guzman, A; Valles, H | 1 |
Gokal, R; Johnson, RW; O'Donoghue, DJ; Short, CD | 1 |
Kovaleva, SI | 1 |
Pust, RE | 1 |
Kleeberg, HH; Weyer, K | 1 |
Lumb, R; Shaw, D | 1 |
Adrados, M; Díaz, F; García Aguado, C; González Lahoz, JM; Laguna, F; Martínez, R; Puente, S | 1 |
Alexander, M; Held, T; Mielke, M; Reichelt, A; Rössler, W | 1 |
Geiter, LJ | 1 |
Britton, J; Harcombe, A; Kinnear, W; Macfarlane, J | 1 |
Chaisson, RE; Goodman, PC; Hopewell, PC; Sande, MA; Schecter, GF; Small, PM | 1 |
Kuze, F | 1 |
Stazi, C; Stazi, F | 1 |
Lode, H; Schaberg, T | 1 |
Barnum, HN | 1 |
Aziz, A; Aziz, K; Ishaq, M; Siddiqi, SH | 1 |
Elghoul, MT; Joshi, RM; Rizghalla, T | 1 |
Bellon, G; Gallet, S | 1 |
Fischer, P; Merkel, S; Weinecke, W | 1 |
Aeberhardt, G; Bernheim, J; Dautzenberg, B; Gallinari, C; Grosset, J; Lévy, A; Sors, C | 1 |
Farhi, DC; Gangadharam, PR; Iseman, MD; Jairam, BT; Nguyen, AK; Perumal, VK; Rao, PN | 1 |
Gibson, J | 1 |
Chang, CE; Heifets, LB; Lin, TP; Suo, J | 1 |
Li, CH; Li, XC | 1 |
Baskin, GB; Gibson, SV; Watson, EA; Wolf, RH | 1 |
Davidson, PT; Hanh, LQ | 1 |
Gao, DZ | 1 |
Baron, EJ; Young, LS | 1 |
Crowle, AJ; Judson, FN; May, MH; Sbarbaro, JA | 1 |
Leff, AR; Leff, DR | 1 |
Berfelo, WF; Greve, LH; Hupperts, RM; Janevski, B; Vreeling, FW; Willebrand, D; Wouters, EF | 1 |
Behera, D; Malik, SK | 1 |
Jancik, E | 1 |
Rosenfeld, M | 1 |
Press, P | 1 |
Frenk, E; Smith, AJ; Walker, AE | 1 |
Hellström, PE; Mattson, K; Repo, UK | 1 |
Zwolska-Kwiek, Z | 2 |
Citron, KM | 1 |
Arima, J; Igarashi, H | 1 |
Pätiälä, J; Tani, P | 1 |
Eule, H; Iwainsky, H; Krebs, A | 1 |
Zierski, M | 1 |
Boman, G; Ringberger, VA | 1 |
Shimizu, T | 1 |
Dickinson, JM | 2 |
Abbott, MR | 1 |
Lakshminarayan, S; Petty, TL; Pierson, DJ | 1 |
Heymer, A; Schwabe, HK; Stollenwerk, M; Wahlen, A | 1 |
Swinburn, PD | 1 |
Bernardi, L; Foglio, M; Temperilli, A | 1 |
Regli, J; Ziegler, WJ | 1 |
Burkes, J; Stottmeier, KD | 1 |
Deshayes, P; Desseauve, P; Houdent, G; Lemercier, JP; Morere, P; Simonin, JL | 1 |
Morax, S; Pesme, D; Vérin, P; Yacoubi, M | 1 |
Amemiya, K; Kato, M; Komatsu, N; Nagumo, N; Saga, K | 1 |
Charachon, R; Faivre, A; Junien-Lavillauroy, C; Roux, O | 1 |
Hokama, S | 3 |
Gartmann, J | 1 |
Virchow, C | 1 |
Heaf, PJ | 1 |
Charles, A; Demonet, B; Germouty, J; Serizay, B | 1 |
Freerksen, E; Matsumiya, T; Rosenfeld, M | 2 |
Suzuki, T | 1 |
Makarevich, NM; Rudoĭ, NM | 1 |
Bethge, H | 1 |
Hudson, LD; Sbarbaro, JA | 1 |
Burgher, LW; Kass, I | 1 |
Eule, H; Grobb, V; Hager, G | 1 |
Barranger, C; Boury, G; Favre, M; Houdard, C; Lancastre, F; Le Fichoux, Y; Mafart, Y; Piéron, R | 1 |
Wolinsky, E | 1 |
Blanchon, B; Blanchon, F; Blanchon, P; Groseille, Y; Holler, A; Paillas, J | 1 |
Pau, H | 1 |
Härö, AS; Hjaltested, OP; Nielsen, E | 1 |
Grosse-Brockhoff, F; Hausamen, TU; Peters, U | 1 |
Barbier, JP; Carnot, F; Cornet, A; Cornu, P; Dubrisay, J; Hirsch, JF | 1 |
Drozdowska, S; John, W | 1 |
Bayliss, CG | 1 |
Aquinas, M | 1 |
Walker, AS | 1 |
Berthelon, S; Hermans, G; Toth, LC | 1 |
Eule, H; Lucchesi, M; Ozgen, ZS; Zierski, M | 1 |
Tsukamura, M | 1 |
Ashba, JK; Boyce, JM | 1 |
Cappucci, DT; O'Shea, JL; Smith, GD | 1 |
Dürr, DK; Wissler, H | 1 |
Douma, J | 1 |
Evans, C; Proust, A | 1 |
Dobrzyński, W; Joblonowski, Z; Kisielewicz, J; Kociecka, I; Turczynowski, R | 1 |
Schmidt, W | 1 |
Rudnicka, M; Szymaczek-Meyer, L; Westfal, I; Wiza, J | 1 |
Róka, L; Zeller, F | 1 |
Rausch, R; Schwabe, HK; Thiesen, GJ | 1 |
Drabkina, RO; Ginzburg, TS | 1 |
Mattson, K | 1 |
Gwóźdź, E; Krych, J; Lichoń, W; Matusik-Rutkowska, A; Zyczyński, T | 1 |
Riordan, DC; Williams, CS | 1 |
Ellis, PP; Littlejohn, K | 1 |
Boman, G; Dahlström, G; Hanngren, A; Stavenow, S; Wiman, LG | 1 |
Radenbach, KL | 1 |
Grzybowshi, S | 1 |
Bartel, AG; Kelley, WN; Postlethwaite, AE | 1 |
Davidson, PT; Sahn, SA | 1 |
Bechetoille, A; Nou, B; Saraux, H | 1 |
Gerbeaux, J | 1 |
Aoyagi, T; Gomi, J | 1 |
Krebs, A | 1 |
Trendelenburg, F | 1 |
Delli Veneri, F; Marra, A; Nitti, V | 1 |
Riska, N | 1 |
Schütz, I | 1 |
Grassi, C | 1 |
Favez, G | 2 |
Pyle, MM | 2 |
El'nik, VI | 1 |
Daniel, TM | 1 |
Dickinson, JM; Ellard, GA; Mitchison, DA | 1 |
Erhard, G | 1 |
Hayashi, I; Konno, K; Oizumi, K; Shimizu, Y | 1 |
Canetti, G; Grumbach, F; Le Lirzin, M | 1 |
Janowiec, M | 3 |
Bechcińska, B; Cyperling, I; Rozniecki, J; Sosnowski, W; Tomaszkiewicz, L | 1 |
Okamoto, K; Terunuma, K; Watanabe, S | 1 |
Chazalette, JP; Dutruge, J; Gilly, R; Viallier-Raynard, J | 1 |
Pregowski, W | 1 |
Zorini, AO | 1 |
Kanther, R | 1 |
Grumbach, F | 1 |
Nitti, V | 1 |
Ota, Y | 1 |
Ariji, F; Kumano, N; Madokoro, K; Oka, S; Yamaguchi, J | 1 |
Fadeeva, EA; Gol'dshteĭn, VD; Prokhorov, EP | 1 |
Stärk, N | 1 |
Jaskula-Kossak, E; Swica-Gardzilewicz, A | 1 |
Gol'dshteĭn, VD; Kubyshkina, VF; Poliakova, SG; Rabukhin, AE | 1 |
Motomura, K; Ogawa, T | 1 |
Tousek, J | 1 |
Diaconiţă, G | 1 |
Kramer, R; Simon, K | 1 |
Crofton, J | 1 |
Buyske, DA; Little, RR; Peets, EA; Place, VA | 1 |
Bobrowitz, ID | 1 |
Perfeito, JB | 1 |
Bek-Lissnerowa, E; Kwiekowa, A | 1 |
Pahlitzsch, H; Tiburtius, H | 1 |
Marécaux, L; Tricoire, J | 1 |
Gallindo, IS; Hammerli, A | 1 |
Brun, J; Fougerat, J; Kalb, JC; Kofman, J; Perrin-Fayolle, M | 1 |
Molina, C; Rouher, F; Sole, P | 1 |
Sunahara, S | 1 |
Repo, UK | 1 |
Hobby, GL; Lenert, TF | 1 |
Unholtz, K | 1 |
Gerbeaux, J; Hanoteau, J | 1 |
Repo, K; Riska, N | 1 |
Chenebault, J | 2 |
Tiburtius, H | 1 |
Kradolfer, F | 1 |
Fossati, C | 1 |
Yoshida, F | 1 |
Orlowski, EH | 1 |
Fukuhara, T; Mitsui, M; Sasaoka, A; Yoshida, F | 1 |
Tveit, J | 1 |
Kradolfer, F; Schnell, R | 1 |
Ehring, F | 1 |
Mitchell, RS | 1 |
Korotaev, GA; Kozulitsyna, TI | 1 |
Hellestrand, AL | 1 |
Trendelenburg, F; Virchow, C | 1 |
Daddi, G; Lucchesi, M; Mancini, P | 1 |
Lucchesi, M; Mancini, P; Matzeu, M | 1 |
Nahum, LH | 1 |
Pantalone, T; Scialdone, D | 1 |
59 review(s) available for ethambutol and Koch's Disease
Article | Year |
---|---|
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Mycobacterium tuberculosis; Rifamycins; Tuberculosis | 2009 |
Recent advances in antitubercular natural products.
Topics: Animals; Antitubercular Agents; Biological Products; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Mycobacterium tuberculosis; Tuberculosis | 2012 |
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis | 2013 |
Isoniazid derivatives and their anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Triazole derivatives and their anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2017 |
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship; Tuberculosis | 2017 |
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Tuberculosis | 2021 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Ethambutol; HIV; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Tuberculosis treatment in children: The changing landscape.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Central Nervous System; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Tuberculosis in 2019.
Topics: Antitubercular Agents; Ethambutol; Health Policy; Humans; India; Isoniazid; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Practice Guidelines as Topic; Pulmonologists; Pyrazinamide; Rifampin; Surveys and Questionnaires; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2020 |
Pharmacokinetics of First-Line Anti-Tubercular Drugs.
Topics: Age Factors; Antitubercular Agents; Child; Drug Overdose; Ethambutol; Food; Genotype; HIV Infections; Humans; Isoniazid; Malnutrition; Nutritional Status; Polymorphism, Genetic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2019 |
Isolated tuberculous liver abscess in an immunocompetent adult patient: A case report and literature review.
Topics: Aged; Antitubercular Agents; Biopsy; Blood Chemical Analysis; Drug Combinations; Ethambutol; Humans; Isoniazid; Laparotomy; Liver; Liver Abscess; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Understanding pharmacokinetics to improve tuberculosis treatment outcome.
Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifamycins; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary | 2014 |
Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Topics: Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Evolution, Chemical; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Progress on mechanism of ethambutol resistance in Mycobacterium Tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Ethambutol; Humans; Mycobacterium tuberculosis; Tuberculosis | 2016 |
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment.
Topics: Adolescent; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Graft Rejection; Humans; Isoniazid; Liver Failure, Acute; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prognosis; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review.
Topics: Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pacemaker, Artificial; Recurrence; Rifampin; Surgical Wound Infection; Tomography, X-Ray Computed; Tuberculosis | 2009 |
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.
Topics: Animals; Antitubercular Agents; Drug Design; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Physiological Phenomena; Pyrazinamide; Rifamycins; Streptomycin; Thiophenes; Tuberculosis; Tuberculosis, Pulmonary | 2008 |
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis | 2010 |
[Not just a success story. On the history of tuberculosis treatment].
Topics: Antitubercular Agents; Ethambutol; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Medieval; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculin; Tuberculosis | 2012 |
Incidence of ethambutol-related visual impairment during treatment of active tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Humans; Incidence; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Time Factors; Tuberculosis; Vision Disorders; Vision Tests; Vision, Ocular; Young Adult | 2013 |
[Tuberculosis].
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Ethambutol; France; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 2002 |
Ocular ethambutol toxicity.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Optic Nerve Diseases; Tuberculosis | 2003 |
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Lymphocyte Count; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifabutin; Tuberculosis | 2007 |
Ethambutol.
Topics: Animals; Antitubercular Agents; Ethambutol; Humans; Treatment Outcome; Tuberculosis | 2008 |
Prevention and management of tuberculosis in HIV positive patients living in countries with a low prevalence of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cross Infection; Emigration and Immigration; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Patient Isolation; Prevalence; Tuberculin Test; Tuberculosis; United Kingdom | 1996 |
New horizons in the treatment of tuberculosis.
Topics: Animals; Drug Design; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycolic Acids; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature.
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Eye Diseases; Female; Follow-Up Studies; Humans; Male; Tuberculosis | 1997 |
[Antitubercular chemotherapy].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Combinations; Ethambutol; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss | 1997 |
Ethambutol in tuberculosis: time to reconsider?
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Developing Countries; Drug Administration Schedule; Ethambutol; Humans; Malawi; Tuberculosis | 1998 |
A current approach to the management of tuberculosis infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; BCG Vaccine; Ethambutol; Forecasting; Humans; Immunocompetence; Isoniazid; Mass Screening; Patient Compliance; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2000 |
DNA microarrays and combinatorial chemical libraries: tools for the drug discovery pipeline.
Topics: Antitubercular Agents; Drug Design; Ethambutol; Gene Expression; Humans; Isoniazid; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Tuberculosis | 2000 |
[Optic injury by ethambutol and its prophylaxis and treatment].
Topics: Antitubercular Agents; Ethambutol; Humans; Optic Nerve Injuries; Tuberculosis; Vision Disorders | 2000 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Advances in the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1976 |
Diagnosis and management of tuberculosis.
Topics: Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; BCG Vaccine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 1979 |
Chemotherapy of tuberculosis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1976 |
Diagnosis, prevention and early therapy of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Mycobacterium tuberculosis; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Cardiovascular; Tuberculosis, Female Genital; Tuberculosis, Lymph Node; Tuberculosis, Male Genital; Tuberculosis, Meningeal; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Renal; United States | 1976 |
Failure of therapy for tuberculosis in human immunodeficiency virus infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 1992 |
[Chemoprophylaxis of tuberculosis (lecture)].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; BCG Vaccine; Child; Ethambutol; Humans; Infant, Newborn; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1992 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Contraindications; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1990 |
[Which treatment for primary tuberculosis?].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
Respiratory pharmacology. Antituberculosis drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cyclosporins; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1986 |
[Results of chemotherapy in tuberculosis].
Topics: Ambulatory Care; Anti-Bacterial Agents; Antitubercular Agents; Drug Synergism; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Peptides; Pyrazinamide; Thioacetazone; Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Urogenital; Viomycin | 1971 |
Therapeutics. XVII. "Reserve" drugs in the treatment of tuberculosis.
Topics: Chemical and Drug Induced Liver Injury; Costs and Cost Analysis; Drug Eruptions; Drug Resistance, Microbial; Ethambutol; Humans; Liver; Optic Neuritis; Rifampin; Thioacetazone; Tuberculosis | 1972 |
Tuberculosis.
Topics: Aminosalicylic Acids; Bronchitis; Cough; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Mass Screening; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Tuberculosis therapy. Review on today's knowledge, developmental trends and still open problems].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Germany, West; Humans; Isoniazid; Length of Stay; Rifampin; Streptomycin; Tuberculosis | 1973 |
New trends in the chemotherapy of tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1974 |
Advances in the treatment of respiratory disorders.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aerosols; Asthma; Bronchitis; Chromones; Chronic Disease; Ethambutol; Humans; Mycoplasma Infections; Respiratory Insufficiency; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Tuberculosis; Tuberculosis, Pulmonary; Virus Diseases | 1969 |
[Chemotherapy for tuberculosis (ethambutol, Capreomycin, etc.)].
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Tuberculosis | 1967 |
[Experimental chemotherapy of tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1969 |
[New drugs in antitubercular therapy].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; RNA Nucleotidyltransferases; Tuberculosis; Tuberculosis, Pulmonary | 1969 |
[New anti-tubercular agents--rifampicin and ethambutol].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
[New antitubercular drugs and their clinical use].
Topics: Administration, Oral; Age Factors; Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Fasting; Humans; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1971 |
Myambutol: chemistry, pharmacology, and toxicology.
Topics: Administration, Oral; Animals; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Ethambutol; Female; Humans; Lethal Dose 50; Male; Mice; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Oxidation-Reduction; Rats; Tuberculosis; Tuberculosis, Urogenital | 1970 |
37 trial(s) available for ethambutol and Koch's Disease
Article | Year |
---|---|
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2020 |
The use of optical coherence tomography for the detection of ocular toxicity by ethambutol.
Topics: Adult; Ethambutol; Female; Humans; Male; Middle Aged; Retina; Retinal Diseases; Tomography, Optical Coherence; Tuberculosis; Visual Acuity | 2018 |
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.
Topics: Adult; Antibiotics, Antitubercular; Contact Tracing; Cost-Benefit Analysis; Ethambutol; Family Characteristics; Female; Global Burden of Disease; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Vietnam | 2019 |
Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Color Perception; Contrast Sensitivity; Ethambutol; Female; Humans; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Toxic Optic Neuropathy; Tuberculosis; Visual Field Tests | 2019 |
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Topics: Adult; Ambulatory Care Facilities; Antitubercular Agents; Canada; Directly Observed Therapy; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis; United States | 2014 |
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Disinfection; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Sterilization; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial.
Topics: Adolescent; Antitubercular Agents; Body Height; Body Mass Index; Body Weight; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Micronutrients; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Zinc | 2014 |
A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Users; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Tuberculosis | 2015 |
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
Topics: Antitubercular Agents; Decision Support Techniques; Ethambutol; Humans; Isoniazid; Markov Chains; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Body Weight; Chemical and Drug Induced Liver Injury; Curcuma; Drug Therapy, Combination; Ethambutol; Female; Hemoglobins; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Patient Compliance; Plant Preparations; Pyrazinamide; Rifampin; Tinospora; Treatment Outcome; Tuberculosis | 2008 |
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Pyrazinamide; Rifampin; Tuberculosis; Viral Load | 2010 |
Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Directly Observed Therapy; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis; Young Adult | 2009 |
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Ethambutol; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Uganda; Viral Load; Young Adult | 2010 |
Visual function in patients on ethambutol therapy for tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Color Vision; Ethambutol; Female; Humans; Male; Prospective Studies; Treatment Outcome; Tuberculosis; Vision, Ocular; Visual Acuity; Visual Fields; Young Adult | 2012 |
Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; HIV Infections; Humans; Incidence; India; Isoniazid; Male; Middle Aged; Treatment Outcome; Tuberculosis | 2012 |
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
Topics: Analysis of Variance; Antibiotics, Antitubercular; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Therapeutic Equivalency; Time Factors; Tuberculosis | 2002 |
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Topics: Acetylation; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Ethambutol; Feces; Female; HIV Infections; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Phenotype; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study.
Topics: Adult; Antitubercular Agents; Ethambutol; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Prospective Studies; Tuberculosis; Visual Acuity | 2003 |
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Therapeutic Equivalency; Tuberculosis | 2005 |
Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Antitubercular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Eye Diseases; Female; Humans; Male; Microbial Sensitivity Tests; Recurrence; Retrospective Studies; Rifampin; Tuberculosis | 2007 |
Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Linear Models; Male; Mass Spectrometry; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Topics: Adolescent; Adult; Aged; Alcoholism; Clinical Trials as Topic; Denmark; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1982 |
Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis | 1994 |
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis | 1997 |
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
Topics: Antibiotics, Antitubercular; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Colorimetry; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Quality Control; Reference Values; Rifampin; Therapeutic Equivalency; Tuberculosis; Urinalysis | 2001 |
Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.
Topics: Adult; Ambulatory Care; Antitubercular Agents; Caregivers; Directly Observed Therapy; Ethambutol; Feasibility Studies; Female; Humans; Isoniazid; Malawi; Male; Patient Compliance; Pilot Projects; Program Evaluation; Self Administration; Tuberculosis | 2001 |
Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Desensitization, Immunologic; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome; Treatment Outcome; Tuberculosis | 2001 |
[Hepatoxic side-effects of rifampicin. A comparative clinical study].
Topics: Alanine Transaminase; Alcoholism; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
[A comparison of the therapeutic efficacy of two drug combinations in cases of previously untreated open tuberculosis (author's transl)].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Streptomycin; Tuberculosis | 1978 |
Rifampicin, myambutol, Isoxyl, and capreomycin as combination partners in animal experiments.
Topics: Animals; Antitubercular Agents; Capreomycin; Clinical Trials as Topic; Drug Combinations; Ethambutol; Mycobacterium Infections; Phenylthiourea; Rabbits; Rifampin; Tuberculosis | 1970 |
[Double blind study of the toxicity of different doses of ethambutol given in an intermittent therapeutic regimen with streptomycin, isoniazide and ethambutol].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Placebos; Streptomycin; Tuberculosis | 1973 |
Methods of clinical evaluation of rifampicin-activity.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
[Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
Hospital-based ambulatory treatment of tuberculosis with capreomycin, ethambutol, and-or rifampicin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Clinical Trials as Topic; Ethambutol; Finland; Humans; Physician-Patient Relations; Rifampin; Tuberculosis | 1969 |
A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. Preliminary results of the third cooperative study of the WATL.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
[Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
Topics: Adult; Antitubercular Agents; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Ethambutol; Female; Humans; Isonicotinic Acids; Male; Middle Aged; Rifampin; Tuberculosis | 1969 |
Clinical applications of ethambutol.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Child, Preschool; Clinical Trials as Topic; Cycloserine; Diabetes Mellitus; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Liver Cirrhosis; Male; Mycoplasma Infections; Pregnancy; Streptomycin; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1969 |
579 other study(ies) available for ethambutol and Koch's Disease
Article | Year |
---|---|
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Topics: Animals; Antitubercular Agents; Blood; Cell Line; Humans; In Vitro Techniques; Intracellular Membranes; Macrophages; Mammals; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium; Mycobacterium bovis; Mycolic Acids; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis | 2006 |
A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.
Topics: Anti-Bacterial Agents; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Piperidones; Pyrrolidines; Spiro Compounds; Tuberculosis | 2009 |
Synthesis and evaluation of (S,S)-N,N'-bis-[3-(2,2',6,6'-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity.
Topics: Antitubercular Agents; Azepines; Benzhydryl Compounds; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ethylenediamines; Mycobacterium tuberculosis; Tuberculosis | 2009 |
Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Rifampin; Structure-Activity Relationship; Tuberculosis | 2009 |
Synthesis and anti-mycobacterial activity of novel amino alcohol derivatives.
Topics: Amino Alcohols; Antitubercular Agents; Ethambutol; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2011 |
Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction.
Topics: Antitubercular Agents; Carbazoles; Humans; Imines; Models, Molecular; Mycobacterium tuberculosis; Pyrans; Quinolines; Structure-Activity Relationship; Tuberculosis | 2011 |
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; NIH 3T3 Cells; Quinolines; Structure-Activity Relationship; Thiadiazoles; Tuberculosis | 2011 |
Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.
Topics: 2,2'-Dipyridyl; Anions; Antitubercular Agents; Calixarenes; Guanidine; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Quaternary Ammonium Compounds; Tuberculosis | 2012 |
Synthesis, characterization and in vitro biological evaluation of some novel 1,3,5-triazine-Schiff base conjugates as potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Humans; Mycobacterium tuberculosis; Schiff Bases; Triazines; Tuberculosis | 2013 |
Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Humans; Indoles; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Rats; Solubility; Structure-Activity Relationship; Tuberculosis | 2013 |
Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Benzofurans; Click Chemistry; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2014 |
Multitarget drug discovery for tuberculosis and other infectious diseases.
Topics: Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Bacteria; Breast Neoplasms; Cell Proliferation; Drug Design; Drug Discovery; Female; Fungi; Humans; Malaria, Falciparum; MCF-7 Cells; Membrane Transport Proteins; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship; Tuberculosis; Tumor Cells, Cultured | 2014 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Topics: Acetamides; Animals; Bacterial Proteins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2014 |
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Benzoxazoles; Cell Line; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Structure-Activity Relationship; Tuberculosis | 2014 |
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Phenazines; Pyrrolidines; Quinolizidines; Structure-Activity Relationship; Tuberculosis; Vero Cells | 2014 |
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proton-Translocating ATPases; Quinolines; Rats, Sprague-Dawley; Sulfonamides; Tuberculosis | 2015 |
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Topics: Animals; Antifungal Agents; Antioxidants; Antitubercular Agents; Benzimidazoles; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiadiazoles; Tuberculosis; Vero Cells | 2015 |
Guanidinium compounds with sub-micromolar activities against Mycobacterium tuberculosis. Synthesis, characterization and biological evaluations.
Topics: Antitubercular Agents; Guanidine; Humans; Models, Molecular; Mycobacterium tuberculosis; Tuberculosis | 2015 |
Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Chlorocebus aethiops; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyrimidines; Triazoles; Tuberculosis; Vero Cells | 2015 |
Synthesis and anti-tuberculosis activity of glycitylamines.
Topics: Amines; Antitubercular Agents; Colorimetry; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2016 |
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Binding Sites; Catalytic Domain; Formazans; Gallic Acid; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Tuberculosis | 2017 |
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Drug Development; Humans; Mycobacterium tuberculosis; Tuberculosis | 2018 |
Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Drug Design; HEK293 Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Topics: Antitubercular Agents; Carbamates; Hep G2 Cells; Humans; Isocitrate Lyase; Mycobacterium tuberculosis; Phenols; Salicylanilides; Tuberculosis | 2019 |
Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Topics: Amination; Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Thiazoles; Tuberculosis | 2020 |
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells | 2022 |
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Topics: Adult; Antitubercular Agents; Child; Drug Combinations; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2022 |
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2021 |
Importance of asking a social history: atypical pulmonary infections and occupational hazards.
Topics: Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2022 |
The role of 99mTc-ethambutol scintigraphy to diagnose pulmonary tuberculosis.
Topics: Ethambutol; Humans; Mycobacterium tuberculosis; Radionuclide Imaging; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 2022 |
Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: Implications for dose selection.
Topics: Animals; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Lung; Mice; Pyrazinamide; Tuberculosis | 2022 |
Molecular insights of hyaluronic acid - ethambutol and hyaluronic acid - isoniazid drug conjugates act as promising novel drugs for the treatment of tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Hyaluronic Acid; Isoniazid; Molecular Docking Simulation; Mycobacterium tuberculosis; Pharmaceutical Preparations; Tuberculosis | 2023 |
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
Topics: Animals; Antitubercular Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prothionamide; Pyrazinamide; Reactive Oxygen Species; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Ethambutol-induced optic neuropathy.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Optic Nerve; Optic Nerve Diseases; Tomography, Optical Coherence; Tuberculosis | 2023 |
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study.
Topics: Antitubercular Agents; Child; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tanzania; Tuberculosis; United States | 2022 |
Prevalence and Drug Resistance Pattern of
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iraq; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2022 |
From Scylla to Charybdis: Fixed drug combinations for tuberculosis and increased ethambutol-induced optic neuropathy in India.
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; India; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis | 2022 |
The Gene and Regulatory Network Involved in Ethambutol Resistance in
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2023 |
Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Imipenem; Linezolid; Mice; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Pentosyltransferases; Permeability; Rifabutin; Tuberculosis | 2022 |
Tuberculosis: Common Questions and Answers.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; Tuberculin; Tuberculosis; United States | 2022 |
Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment.
Topics: Anti-Bacterial Agents; Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium kansasii; Retrospective Studies; Rifampin; Tuberculosis | 2023 |
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis | 2022 |
Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Substandard Drugs; Tablets; Tuberculosis | 2022 |
[An atypical presentation of tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
A high-throughput LC-MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Pyrazinamide; Tandem Mass Spectrometry; Tuberculosis | 2023 |
Ocular Toxicity of Ethambutol During Both Intensive and Continuation Phases of Anti-Tubercular Therapy in Children.
Topics: Antitubercular Agents; Child; Ethambutol; Humans; Prospective Studies; Retina; Toxic Optic Neuropathy; Tuberculosis | 2022 |
The patterns and distribution of female genital tuberculosis among Togolese patients.
Topics: Adult; Cross-Sectional Studies; Ethambutol; Female; HIV Infections; Humans; Tuberculosis; Tuberculosis, Female Genital | 2022 |
Evaluation Study of xMAP TIER Assay on a Microsphere-Based Platform for Detecting First-Line Anti-Tuberculosis Drug Resistance.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
An efficient CRISPR interference-based prediction method for synergistic/additive effects of novel combinations of anti-tuberculosis drugs.
Topics: Antitubercular Agents; Clustered Regularly Interspaced Short Palindromic Repeats; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Mycobacterium tuberculosis; Tuberculosis | 2023 |
Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ethambutol; Humans; Microbial Sensitivity Tests; Prospective Studies; Tuberculosis | 2023 |
In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Sphingosine; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
A physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Topics: Antitubercular Agents; Bayes Theorem; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Reference Standards; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2023 |
Uncommon but Clinically Significant: Bacillus Calmette-Guerin (BCG) Infection of the Urinary Tract and its Impact on Quality of Life.
Topics: Aged; Aged, 80 and over; BCG Vaccine; Ethambutol; Humans; Isoniazid; Male; Mycobacterium bovis; Quality of Life; Tuberculosis; Urinary Bladder Neoplasms; Urinary Tract | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |
Protein binding investigation of first-line and second-line antituberculosis drugs.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Moxifloxacin; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Therapeutic Liquid Eutectic Solvents in Lipid Nanoparticles as Drug Vehicles-A Proof of Concept.
Topics: Ethambutol; Excipients; Humans; Liposomes; Solvents; Tuberculosis | 2023 |
Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
Topics: Antihypertensive Agents; Antitubercular Agents; Diabetes Mellitus; Ethambutol; Humans; Hypertension; Hypoglycemic Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pharmaceutical Preparations; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Determinants of serum concentration of first-line anti-tuberculosis drugs from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; China; Chromatography, Liquid; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Smoking; Tuberculosis; Young Adult | 2019 |
[Tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Asian People; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; China; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Genotype; Humans; Isoniazid; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Tuberculosis; Young Adult | 2020 |
Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Reference Standards; Reproducibility of Results; Rifabutin; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tuberculosis | 2020 |
Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.
Topics: Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Immunoblotting; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis | 2020 |
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Topics: Adult; Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis; Whole Genome Sequencing | 2020 |
Tuberculosis sepsis after tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Multiple Organ Failure; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sepsis; Treatment Outcome; Tuberculosis | 2020 |
Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India.
Topics: Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Eye Diseases; Female; Humans; India; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis; Vision Disorders | 2020 |
Primary breast tuberculosis in an HIV-infected patient.
Topics: Adult; Antitubercular Agents; Biopsy; Breast; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2020 |
[Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
Topics: Antitubercular Agents; Ethambutol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2020 |
Zebrafish Embryo Model for Assessment of Drug Efficacy on Mycobacterial Persisters.
Topics: Animals; Ethambutol; Mycobacterium; Pharmaceutical Preparations; Tuberculosis; Zebrafish | 2020 |
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis.
Topics: Antitubercular Agents; Bayes Theorem; Ethambutol; Humans; Isoniazid; Pyrazinamide; Tuberculosis | 2021 |
Tuberculosis drug resistance in Canakkale, Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality.
Topics: Adult; Amikacin; Antibiotics, Antitubercular; APACHE; Brazil; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Intensive Care Units; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 2021 |
Characterisation of macular superficial vessel density alteration in preclinical ethambutol-induced optic neuropathy using optical coherence tomography angiography.
Topics: Angiography; Ethambutol; Humans; Intraocular Pressure; Nerve Fibers; Optic Nerve Diseases; Retinal Ganglion Cells; Retrospective Studies; Tomography, Optical Coherence; Tuberculosis | 2022 |
Point-of-Care Ultrasound Image of Intra-Abdominal Lymphadenopathy in Tuberculosis.
Topics: Abdomen; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Mycobacterium tuberculosis; Point-of-Care Systems; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Ultrasonography; Young Adult | 2020 |
Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen.
Topics: Antitubercular Agents; Blindness; Ethambutol; Humans; India; Optic Nerve Diseases; Tuberculosis | 2021 |
Successful Use of Rifamycin-Sparing Regimens for the Treatment of Active Tuberculosis in Lung Transplant Recipients.
Topics: Ethambutol; Humans; Isoniazid; Lung; Lung Transplantation; Moxifloxacin; Pyrazinamide; Rifamycins; Transplant Recipients; Treatment Outcome; Tuberculosis | 2021 |
A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Ethambutol; Female; Humans; Isoniazid; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2021 |
Isolated multidrug-resistant tubercular tenosynovitis of the flexor tendon of the little finger.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Resistance, Multiple; Ethambutol; Female; Fingers; Humans; Levofloxacin; Linezolid; Magnetic Resonance Imaging; Tendons; Tenosynovitis; Tuberculosis; Young Adult | 2021 |
A novel agar base medium for drug susceptibility testing of
Topics: Agar; Antitubercular Agents; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 2021 |
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2022 |
A 25-Year-Old Woman With a Deceptive Pancreas Cyst: All Is Not as It Appears!
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pancreatic Cyst; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis | 2018 |
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Variation; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mitoxantrone; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Rifampin; Sequence Analysis; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs).
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genes, Reporter; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Rifampin; Tuberculosis | 2017 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Tuberculosis of the tonsil simulating a cancer.
Topics: Adenoids; Adult; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
Diagnostic value of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Ethambutol; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Tuberculosis; Young Adult | 2018 |
New insights on Ethambutol Targets in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Cell Wall; Ethambutol; Humans; Metabolic Networks and Pathways; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Proteome; Time Factors; Tuberculosis | 2019 |
Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation.
Topics: Antitubercular Agents; Automation, Laboratory; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2018 |
First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Ethambutol; Female; Humans; Isoniazid; Liver; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Purines; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2018 |
Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
Topics: Antitubercular Agents; Caffeic Acids; Crystallization; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Models, Molecular; Pyrazinamide; Rifampin; Tuberculosis; Vanillic Acid | 2018 |
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Lost to Follow-Up; Male; Multivariate Analysis; Patient Discharge; Patient Transfer; Prisoners; Prisons; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Risk Factors; Sputum; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2018 |
Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy.
Topics: Antitubercular Agents; Clinical Trials as Topic; Electrocardiography; Ethambutol; Female; Gatifloxacin; Heart Rate; Humans; Isoniazid; Male; Models, Theoretical; Multivariate Analysis; Pyrazinamide; Rifampin; Sex Factors; Tuberculosis | 2018 |
Exposure of Nursed Infants to Maternal Treatment with Ethambutol and Rifampicin.
Topics: Adult; Algorithms; Antitubercular Agents; Breast Feeding; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Infant; Milk, Human; Models, Biological; Rifampin; Tissue Distribution; Tuberculosis | 2018 |
Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Predictive Value of Tests; Pyrazinamide; Reproducibility of Results; Rifampin; Spectrometry, Mass, Electrospray Ionization; Streptomycin; Tandem Mass Spectrometry; Tuberculosis | 2018 |
Improving treatment outcome assessment in a mouse tuberculosis model.
Topics: Administration, Oral; Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Genotype; Humans; Mice; Mice, Inbred BALB C; Models, Theoretical; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2018 |
Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Early Diagnosis; Ethambutol; Female; Humans; Intraocular Pressure; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Retinal Ganglion Cells; ROC Curve; Sensitivity and Specificity; Tomography, Optical Coherence; Tuberculosis; Visual Field Tests; Visual Fields | 2019 |
Protein Binding of First-Line Antituberculosis Drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Dried Blood Spot Testing; Drug Monitoring; Ethambutol; Female; Humans; Infant; Male; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
A Breast Lump in an Elderly Lady - Carcinoma or else ?.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Breast; Breast Neoplasms; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteriocins; Cell Line; Drug Synergism; Ethambutol; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Muramidase; Mycobacterium tuberculosis; RAW 264.7 Cells; Tuberculosis | 2018 |
Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Antitubercular Agents; Cell Line; Drug Therapy, Combination; Ethambutol; Glutathione; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; THP-1 Cells; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Development and biological evaluation of a new nanotheranostic for tuberculosis.
Topics: Animals; Antitubercular Agents; Dynamic Light Scattering; Ethambutol; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Mycobacterium bovis; Nanoparticles; Particle Size; Polymers; Radiopharmaceuticals; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tuberculosis | 2019 |
Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
Topics: Antitubercular Agents; Bacterial Proteins; Drug Synergism; Drug Therapy, Combination; Ethambutol; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis | 2018 |
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Tuberculosis; Whole Genome Sequencing | 2018 |
Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Infant; Isoniazid; Longitudinal Studies; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rural Population; Tanzania; Tuberculosis | 2020 |
A new colorimetric method for rapid detection of ethambutol and streptomycin resistance in Mycobacterium tuberculosis: crystal violet decolorization assay (CVDA).
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Colorimetry; Drug Resistance, Bacterial; Ethambutol; Gentian Violet; Humans; Mycobacterium tuberculosis; Streptomycin; Tuberculosis | 2019 |
Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Discovery; Drug Evaluation, Preclinical; Ethambutol; Humans; Isoniazid; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Recurrence; Sputum; Tuberculosis | 2018 |
Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment.
Topics: Arginine; Caco-2 Cells; Calorimetry, Differential Scanning; Carbon-13 Magnetic Resonance Spectroscopy; Cell Survival; Diffusion; Ethambutol; Humans; Inhibitory Concentration 50; Permeability; Proton Magnetic Resonance Spectroscopy; Solubility; Solvents; Tuberculosis | 2018 |
Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Desensitization, Immunologic; Drug Hypersensitivity; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy.
Topics: A549 Cells; Administration, Inhalation; Antitubercular Agents; Cell Division; Cell Survival; Drug Compounding; Dry Powder Inhalers; Ethambutol; Humans; Liposomes; Materials Testing; Nanoparticles; Particle Size; Tuberculosis | 2019 |
Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.
Topics: Adult; Antitubercular Agents; Autophagy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ethambutol; Humans; Hypoglycemic Agents; Insulin; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Metformin; Microtubule-Associated Proteins; Middle Aged; Pyrazinamide; Rifampin; Sputum; Superoxide Dismutase; Tuberculosis | 2019 |
Linezolid for drug-susceptible tuberculosis.
Topics: Ethambutol; Humans; Linezolid; Prospective Studies; Tuberculosis; Tuberculosis, Pulmonary | 2019 |
Linezolid for drug-susceptible tuberculosis.
Topics: Ethambutol; Humans; Linezolid; Prospective Studies; Tuberculosis; Tuberculosis, Pulmonary | 2019 |
[Recurrent vomiting and headaches in a 26-year-old male patient].
Topics: Adult; Antitubercular Agents; Bronchoalveolar Lavage; Cerebrospinal Fluid; Ethambutol; Headache; Humans; Magnetic Resonance Imaging; Male; Mycobacterium tuberculosis; Sputum; Tomography, X-Ray Computed; Tuberculosis; Vomiting | 2019 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular
Topics: Adenosine Triphosphatases; Amides; Amino Acids; Antitubercular Agents; Cycloserine; Diarylquinolines; Drug Tolerance; Ethambutol; Ethionamide; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Isoniazid; Isoxazoles; Metabolic Networks and Pathways; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis | 2019 |
Novel 4-methoxynaphthalene-
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Coinfection; Drug Combinations; Drug Discovery; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Paracoccidioides; Paracoccidioidomycosis; Tuberculosis | 2019 |
[Primary sinonasal tuberculosis: apropos of a case].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Sinusitis; Mycobacterium tuberculosis; Nasal Obstruction; Nasal Polyps; Pyrazinamide; Rifampin; Tuberculosis | 2013 |
Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in Brazil: an ecological study.
Topics: Antitubercular Agents; Brazil; Drug Combinations; Ethambutol; Health Plan Implementation; Humans; Incidence; Isoniazid; Population Density; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 2013 |
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; Catalase; Codon; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Follow-Up Studies; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Promoter Regions, Genetic; Recurrence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2013 |
Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tandem Mass Spectrometry; Tuberculosis; Young Adult | 2013 |
Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance.
Topics: Blindness; Cost-Benefit Analysis; Decision Trees; Drug Resistance, Bacterial; Ethambutol; Health Care Costs; Humans; Isoniazid; Markov Chains; Prevalence; Probability; Quality-Adjusted Life Years; Sensitivity and Specificity; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2014 |
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis | 2013 |
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Oxazines; Tuberculosis; Tuberculosis, Multidrug-Resistant; Xanthenes | 2013 |
An unusual cause of breast lump: isolated tuberculosis of the breast.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Breast Diseases; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2014 |
Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Diagnostic Errors; Ethambutol; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; India; Isoniazid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Pros and cons of the tuberculosis drugome approach--an empirical analysis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tamoxifen; Tuberculosis | 2014 |
A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India.
Topics: DNA, Intergenic; Drug Resistance, Bacterial; Ethambutol; Genetic Variation; Genotype; Humans; India; Isoniazid; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin; Tuberculosis | 2014 |
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Disparities; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Sex Factors; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Urban Population; Young Adult | 2015 |
Molecular epidemiology of tuberculosis in Sicily, Italy: what has changed after a decade?
Topics: Adult; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Molecular Typing; Mycobacterium tuberculosis; Rifampin; Sicily; Tuberculosis | 2014 |
The safety of ethambutol dihydrochloride dry powder formulations containing chitosan for the possibility of treating lung tuberculosis.
Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Ethambutol; Humans; Lung; Nanoparticles; Particle Size; Powders; Tuberculosis | 2014 |
Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; China; DNA, Bacterial; Ethambutol; Humans; Membrane Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pentosyltransferases; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Ethambutol-related impaired visual function in childrens less than 5 years of age treated for a mycobacterial infection: diagnosis and evolution.
Topics: Antitubercular Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, University; Humans; Infant; Male; Paris; Retrospective Studies; Tuberculosis; Vision Disorders | 2015 |
Safe and effective treatment for patients with isoniazid drug resistance.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
In reply.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.
Topics: Adult; Antitubercular Agents; Coinfection; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis; Uganda | 2015 |
Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.
Topics: Adult; Child, Preschool; Communicable Disease Control; Contact Tracing; Disease Outbreaks; Ethambutol; Europe; Female; Humans; Incidence; Interferon-gamma Release Tests; Isoniazid; Italy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2015 |
Drug-induced hepatotoxicity and tuberculosis in a hospital from the Argentinian northeast: cross-sectional study.
Topics: Adult; Antitubercular Agents; Argentina; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Tuberculosis; Young Adult | 2015 |
In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.
Topics: Animals; Antitubercular Agents; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 2015 |
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Genetic Variation; Genotype; Humans; Indonesia; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China.
Topics: Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Humans; Mycobacterium tuberculosis; Tuberculosis | 2015 |
Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Extracorporeal Membrane Oxygenation; Humans; Male; Renal Dialysis; Respiratory Distress Syndrome; Rifampin; Tuberculosis | 2016 |
The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
Topics: Antitubercular Agents; Body Weight; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2015 |
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; ATP Binding Cassette Transporter, Subfamily B; Ethambutol; Female; Genotype; Humans; Leukocytes, Mononuclear; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Peroxisome-Targeting Signal 1 Receptor; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Time Factors; Tuberculosis; Vitamin D3 24-Hydroxylase | 2016 |
Incidence of toxic optic neuropathy with low-dose ethambutol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Incidence; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Tuberculosis; Vision, Ocular; Young Adult | 2016 |
[CLINICAL EFFECTS OF TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS INFECTION IN PATIENTS AT A SPECIALIZED HOSPITAL IN 2011].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Hospitals, Special; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Coordination Complexes; Copper; Drug Resistance, Bacterial; Drug Synergism; Ethambutol; Humans; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, Liquid; Coinfection; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Spectrometry, Mass, Electrospray Ionization; Treatment Outcome; Tuberculosis | 2016 |
Frequency of mutational changes in the embB among the ethambutol-resistant strains of Mycobacterium tuberculosis in Iran.
Topics: Antitubercular Agents; DNA Mutational Analysis; Drug Resistance, Bacterial; Ethambutol; Gene Frequency; Genotype; Humans; Iran; Microbial Sensitivity Tests; Molecular Typing; Mutation, Missense; Mycobacterium tuberculosis; Pentosyltransferases; Sequence Analysis, DNA; Tuberculosis | 2016 |
[Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid].
Topics: Alanine Transaminase; Antitubercular Agents; Cycloserine; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Hepatitis, Autoimmune; Humans; Isoniazid; Levofloxacin; Liver; Prothionamide; Severity of Illness Index; Tuberculosis; Young Adult | 2016 |
Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
Topics: Animals; Antitubercular Agents; CHO Cells; Cricetulus; Drug Synergism; Ethambutol; Furans; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Seropositivity; Hospitals; Humans; Isoniazid; Logistic Models; Male; Rifampin; Socioeconomic Factors; Treatment Outcome; Tuberculosis | 2016 |
Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Ethambutol; Female; Follow-Up Studies; Hepatitis; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2016 |
Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2008 |
Update on the treatment of tuberculosis.
Topics: Antitubercular Agents; Comorbidity; Directly Observed Therapy; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2008 |
Children and tuberculosis medicines: bridging the research gap.
Topics: Antitubercular Agents; Child; Ethambutol; Humans; Tuberculosis; World Health Organization | 2008 |
Prevalence of tuberculosis drug resistance in 10 provinces of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Reproducibility of Results; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2008 |
Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations.
Topics: Antitubercular Agents; DNA Mutational Analysis; Drug Resistance, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium smegmatis; Mycobacterium tuberculosis; Pentosyltransferases; Plasmids; Tuberculosis | 2009 |
Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
Topics: Antitubercular Agents; Bacterial Proteins; Culture Media; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Humans; India; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Oxazines; Sequence Analysis, DNA; Tuberculosis; Xanthenes | 2009 |
Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
Topics: Adult; Aged; Antitubercular Agents; Bacterial Proteins; Codon; DNA, Intergenic; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Kuwait; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Tuberculosis; Young Adult | 2009 |
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Topics: Amino Acid Sequence; Animals; Antitubercular Agents; Arabinose; Cell Wall; Drug Resistance, Bacterial; Enzyme Inhibitors; Ethambutol; Gene Expression Regulation, Bacterial; Genes, Bacterial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Structure; Mycobacterium; Mycobacterium tuberculosis; Polysaccharides; Racemases and Epimerases; Spiro Compounds; Thiazines; Tuberculosis | 2009 |
Tuberculosis in renal transplant recipients: a Brazilian center registry.
Topics: Antitubercular Agents; Biopsy; Brazil; Ethambutol; Humans; Incidence; Kidney Transplantation; Recurrence; Registries; Retrospective Studies; Tuberculosis | 2009 |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Antitubercular Agents; Aspartate Aminotransferases; Aza Compounds; Ethambutol; Female; Fluoroquinolones; Hepatic Insufficiency; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Streptomycin; Treatment Outcome; Tuberculosis; Young Adult | 2009 |
A rapid and robust liquid chromatography/tandem mass spectrometry method for simultaneous analysis of anti-tuberculosis drugs--ethambutol and pyrazinamide in human plasma.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Humans; Pyrazinamide; Tandem Mass Spectrometry; Tuberculosis | 2009 |
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2009 |
Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Analysis of Variance; beta 2-Microglobulin; Biomarkers; CD4-Positive T-Lymphocytes; Cell Count; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; India; Isoniazid; Neopterin; Pyrazinamide; Receptors, Tumor Necrosis Factor, Type I; Rifampin; Tuberculosis | 2009 |
Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Morocco; Mutation, Missense; Mycobacterium tuberculosis; Streptomycin; Tuberculosis; Young Adult | 2009 |
Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results.
Topics: Antitubercular Agents; Drug Discovery; Ethambutol; Genotype; Humans; Mutation; Mycobacterium tuberculosis; Phenotype; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uzbekistan | 2009 |
In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oleanolic Acid; Rifampin; Tuberculosis | 2010 |
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
Topics: Antitubercular Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Factors; South Africa; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
Incision infection with Mycobacterium tuberculosis after total hip arthroplasty without any primary tuberculosis focus.
Topics: Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Ethambutol; Female; Hip Dislocation, Congenital; Hip Prosthesis; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prosthesis-Related Infections; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
[Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Turkey | 2010 |
One-tube loop-mediated isothermal amplification combined with restriction endonuclease digestion and ELISA for colorimetric detection of resistance to isoniazid, ethambutol and streptomycin in Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Colorimetry; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Streptomycin; Tuberculosis | 2010 |
Mediastina Tuberculosis mass in a three-month-old boy.
Topics: Adrenal Cortex Hormones; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Male; Mediastinal Diseases; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2010 |
Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.
Topics: Adult; Antitubercular Agents; Aza Compounds; Bacteriological Techniques; Clinical Trials as Topic; Drug Monitoring; Ethambutol; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Time Factors; Tuberculosis | 2010 |
[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Hospitals, University; Humans; Immunocompromised Host; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Senegal; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
[Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Respiratory System; Rifampin; Streptomycin; Tuberculosis; Turkey | 2011 |
[Susceptibility of M. tuberculosis to antituberculosis drugs as determined by two methods, in Sucre state, Venezuela].
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Sequence Data; Morbidity; Mutation, Missense; Mycobacterium tuberculosis; Nitrate Reductase; Point Mutation; Prevalence; Rifampin; Sequence Alignment; Sequence Homology, Nucleic Acid; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Venezuela | 2010 |
The variable clinical presentation of tuberculosis otitis media and the importance of early detection.
Topics: Adolescent; Adult; Audiometry, Pure-Tone; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Otitis Media, Suppurative; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Drug susceptibility pattern of Mycobacterium tuberculosis isolates against conventional anti-tuberculosis drugs in Dhaka, Bangladesh.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Young Adult | 2011 |
Tuberculosis-associated chronic kidney disease.
Topics: Antitubercular Agents; Ethambutol; Fever; Humans; Isoniazid; Kidney Failure, Chronic; Male; Pyrazinamide; Renal Dialysis; Rifampin; Tuberculosis; Young Adult | 2011 |
Population pharmacokinetics of ethambutol in South African tuberculosis patients.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Male; Middle Aged; Tuberculosis; Young Adult | 2011 |
[Anti-tuberculosis chemotherapy and management of adverse reactions].
Topics: Aged, 80 and over; Antitubercular Agents; Child; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Liver; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis | 2011 |
Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Flow Cytometry; Humans; Isoniazid; Neutrophils; Phagocytosis; Pyrazinamide; Respiratory Burst; Rifampin; Staphylococcus aureus; Tuberculosis | 2011 |
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Burkina Faso; Chromatography, High Pressure Liquid; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Plasma; Pyrazinamide; Rifampin; Tuberculosis | 2012 |
GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.
Topics: Antitubercular Agents; Capreomycin; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Fluoroquinolones; Genotype; Germany; Humans; Kanamycin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation, Missense; Mycobacterium tuberculosis; Sequence Analysis, DNA; Tuberculosis | 2012 |
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Topics: Adult; Aged; Alcoholism; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Recurrence; Rifampin; Schizophrenia; Sputum; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
A case of isolated pancreatic tuberculosis mimicking pancreatic carcinoma.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pancreatic Diseases; Pancreatic Neoplasms; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2011 |
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Proteins; Catalase; Child; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mutation, Missense; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Tuberculosis; Young Adult | 2012 |
Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru.
Topics: Adolescent; Adult; Alleles; Bacterial Typing Techniques; Bayes Theorem; Databases, Genetic; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Linkage Disequilibrium; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Molecular Typing; Mycobacterium tuberculosis; Peru; Phylogeny; Selection, Genetic; Sputum; Tuberculosis; Young Adult | 2012 |
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Georgia (Republic); Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Retrospective Studies; Rifampin; Risk Assessment; Risk Factors; Sputum; Time Factors; Treatment Outcome; Tuberculosis | 2012 |
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
Topics: Adult; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Ethambutol; Female; HIV Infections; Humans; Incidence; India; Isoniazid; Male; Models, Economic; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Treatment Outcome; Tuberculosis | 2012 |
[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].
Topics: Adult; Antitubercular Agents; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Female; Granulomatous Mastitis; Humans; Isoniazid; Mastitis; Methotrexate; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prednisone; Pyrazinamide; Recurrence; Rifampin; Tuberculosis | 2012 |
Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Optic Nerve Diseases; Population Surveillance; Retrospective Studies; Risk Factors; Taiwan; Tuberculosis; Young Adult | 2012 |
Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Topics: Acetyltransferases; Adolescent; Age Factors; Antitubercular Agents; Area Under Curve; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Infant; Isoniazid; Least-Squares Analysis; Male; Malnutrition; Polymorphism, Genetic; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; Venezuela; World Health Organization | 2012 |
embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis | 2012 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Biological Transport; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Ethambutol; Genotype; Isoniazid; Kanamycin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Protein Structure, Secondary; Protein Structure, Tertiary; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2013 |
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Interactions; Ethambutol; Female; Genotype; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Organophosphonates; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Single Nucleotide; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Tenofovir; Tuberculosis; Young Adult | 2013 |
Simple and rapid discrimination of embB codon 306 mutations in Mycobacterium tuberculosis clinical isolates by a real-time PCR assay using an LNA-TaqMan probe.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Oligonucleotide Probes; Pentosyltransferases; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors; Tuberculosis | 2013 |
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Citrulline; Drug Administration Schedule; Enzyme Inhibitors; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Nitric Oxide; Nitrites; Pyrazinamide; Rifampin; T-Lymphocyte Subsets; Tuberculosis | 2002 |
Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.
Topics: Agar; Antitubercular Agents; Culture Media; Drug Resistance, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Reproducibility of Results; Tuberculosis | 2002 |
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci).
Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2002 |
Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2003 |
Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Topics: Administration, Oral; Antibiotics, Antitubercular; Antitubercular Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Feasibility Studies; Humans; Isoniazid; Powders; Pyrazinamide; Rifampin; Tuberculosis | 2003 |
A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Drug Combinations; Drug Labeling; Drug Packaging; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pilot Projects; Pyrazinamide; Rifampin; Tablets; Time Factors; Tuberculosis | 2003 |
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Interactions; Ethambutol; Female; Iron; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Survival Rate; Time Factors; Treatment Outcome; Tuberculosis | 2003 |
Ethambutol sensitivity test.
Topics: Antitubercular Agents; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis | 2003 |
Ethambutol in experimental murine tuberculosis. Relation of effectiveness of antimicrobial drugs to immunity.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Ethambutol; Humans; Mice; Tuberculosis; Tuberculosis, Ocular | 1963 |
[Action of ethambutol on experimental tuberculosis in the guinea pig].
Topics: Alcohols; Antitubercular Agents; Ethambutol; Guinea Pigs; Tuberculosis | 1962 |
[THERAPEUTIC EFFECTS OF ETHAMBUTOL (DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL) AND HON (ALPHA-HYDROXY-GAMMA-OXO-L-NORVALINE) ON EXPERIMENTAL TUBERCULOSIS].
Topics: 1-Butanol; Antitubercular Agents; Dihydrostreptomycin Sulfate; Ethambutol; Guinea Pigs; Lung; Mice; Research; Spleen; Streptomycin; Tuberculosis; Valine | 1964 |
ANTITUBERCULOSIS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL) (I).
Topics: 1-Butanol; Antitubercular Agents; Culture Media; Drug Resistance; Drug Resistance, Microbial; Ethambutol; Injections, Subcutaneous; Isoniazid; Mice; Research; Tuberculosis | 1964 |
PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Child; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium Infections; Pharmacology; Prognosis; Pyrazinamide; Streptomycin; Surgical Procedures, Operative; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Viomycin | 1964 |
[ANTITUBERCULOUS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL). (II) COMBINED EFFECT OF ETHAMBUTOL AND ISONIAZID].
Topics: 1-Butanol; Animals; Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Ethambutol; Injections, Intravenous; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Research; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[DRUG TREATMENT OF RENAL TUBERCULOSIS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Phenylthiourea; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Renal; Viomycin | 1964 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
THE ABSORPTION, EXCRETION, AND METABOLIC FATE OF ETHAMBUTOL IN MAN.
Topics: Absorption; Antitubercular Agents; Biological Transport; Blood Chemical Analysis; Body Fluids; Carbon Isotopes; Chromatography; Erythrocytes; Ethambutol; Fluids and Secretions; Humans; Male; Metabolism; Tuberculosis; Tuberculosis, Pulmonary; Urine | 1965 |
CLINICAL STUDIES ON ETHAMBUTOL.
Topics: Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Pharmacology; Radiography, Thoracic; Tomography; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1965 |
CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
Topics: Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Kanamycin; Phenylthiourea; Pyrazinamide; Retreatment; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1965 |
Frequency and antibiotic susceptibility pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Lymph Nodes; Mycobacterium tuberculosis; Pleural Effusion; Rifampin; Streptomycin; Suppuration; Tuberculosis | 2003 |
Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis | 2004 |
[Septic loosening of a Wagner revision stem provoked by Mycobacterium tuberculosis].
Topics: Acetabulum; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Arthroplasty, Replacement, Hip; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radioimmunoassay; Reoperation; Rifampin; Synovial Fluid; Time Factors; Titanium; Tuberculosis | 2003 |
[Cardiac tamponade with paroxysmal atrial flutter controlled by antituberculous therapy].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Atrial Flutter; Cardiac Tamponade; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2004 |
Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Peru; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis | 2004 |
[The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Turkey | 2004 |
Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Deoxyribonucleases, Type II Site-Specific; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Ribosomal Proteins; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2004 |
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biological Availability; Cell Line; Diamines; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethambutol; Female; Injections, Intravenous; Isoniazid; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Mycobacterium tuberculosis; Tissue Distribution; Tuberculosis | 2005 |
Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
Topics: Antitubercular Agents; Ethambutol; Flow Cytometry; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Tuberculosis | 2005 |
A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region.
Topics: Antitubercular Agents; Codon; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Tuberculosis | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Colony Count, Microbial; Combinatorial Chemistry Techniques; Disease Models, Animal; Ethambutol; Ethylenediamines; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Tuberculosis; Vero Cells | 2005 |
Concurrence of granular cell tumor and Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bronchoscopy; Ethambutol; Granular Cell Tumor; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2005 |
Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Saudi Arabia; Streptomycin; Tuberculosis | 2005 |
The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China.
Topics: Adult; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Male; Molecular Epidemiology; Mycobacterium tuberculosis; Tuberculosis | 2005 |
Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Ethambutol; HIV Infections; Humans; Infant; Malnutrition; Pyrazinamide; Tuberculosis | 2006 |
[Mycobacterium novocastrense isolated from sputum: contamination or pulmonary infection?].
Topics: Adult; Antitubercular Agents; Cote d'Ivoire; Diagnosis, Differential; Drug Resistance; Equipment Contamination; Ethambutol; Female; Humans; Mycobacterium; Mycobacterium Infections; Pneumonia, Bacterial; Specimen Handling; Sputum; Tuberculosis | 2006 |
Adverse drug reactions observed during DOTS.
Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Isoniazid; Male; Middle Aged; National Health Programs; Patient Compliance; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 2004 |
Mycobacterium tuberculosis in a Saudi Arabian hospital.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2006 |
Ethambutol-associated optic neuropathy.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Hemianopsia; Humans; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis | 2006 |
[Determination of contents and dissolution of ethambutol hydrochloride in fixed dose combinations for antituberculosis drugs by high performance liquid chromatography with pre-column derivatization].
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Spectrophotometry, Ultraviolet; Tuberculosis | 2006 |
Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Hemianopsia; Humans; Isoniazid; Kidney Failure, Chronic; Male; Optic Neuritis; Renal Dialysis; Rifampin; Tuberculosis | 2006 |
Visual evoked responses in children with tuberculosis treated with ethambutol.
Topics: Child; Child, Preschool; Ethambutol; Evoked Potentials, Visual; Humans; Tuberculosis | 2007 |
Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Cells, Cultured; Colorimetry; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Phagocytosis; Quinolines; Rifampin; Spectrometry, Fluorescence; Tuberculosis; Xanthenes | 2007 |
[Case report: tuberculosis of parotid gland].
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Lymph Node Excision; Male; Parotid Diseases; Parotid Gland; Pyrazinamide; Radiography; Rifampin; Tuberculosis | 2007 |
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Delivery Systems; Ethambutol; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Specific Pathogen-Free Organisms; Tuberculosis | 2007 |
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Tuberculosis | 2007 |
Liver and pancreatic injury induced by antituberculous therapy.
Topics: Adult; Antitubercular Agents; Biopsy; Chemical and Drug Induced Liver Injury; Cholangiopancreatography, Endoscopic Retrograde; Ethambutol; Female; Follow-Up Studies; Humans; Pancreatitis; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2007 |
Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
Topics: Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Rifampin; Streptomycin; Tuberculosis | 2007 |
Tuberculosis peritonitis.
Topics: Aged; Antitubercular Agents; Dominican Republic; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peritonitis; Rhode Island; Rifampin; Tuberculosis | 2007 |
[Experimental therapy with so-called "minor" tuberculostatics].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; Kanamycin; Mice; Phenylthiourea; Pyrazinamide; Rabbits; Tuberculosis; Tuberculosis, Avian | 1966 |
Tuberculosis in chronic renal failure.
Topics: Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Mycobacterium avium; Rifampin; Tuberculosis | 1980 |
Antituberculous drugs in pregnancy.
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Tuberculosis | 1981 |
Guidelines for short-course tuberculosis chemotherapy. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control Atlanta, Ga.
Topics: Centers for Disease Control and Prevention, U.S.; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis; United States | 1980 |
[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1983 |
Management of tuberculosis in elderly persons.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1984 |
[Combined effect of tuberculosis and pesticides on the morphofunctional status of the liver].
Topics: Animals; Chemical and Drug Induced Liver Injury; Drug Interactions; Ethambutol; Liver; Organothiophosphorus Compounds; Rabbits; Rifampin; Tuberculosis | 1983 |
[Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
Topics: Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Hospitalization; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1983 |
An overview of tuberculosis in the 1980s.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Patient Education as Topic; Pregnancy; Rifampin; Tuberculosis | 1983 |
Present chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1982 |
Ethambutol dose-plasma level correlation studies in guinea pigs.
Topics: Animals; Disease Models, Animal; Ethambutol; Female; Guinea Pigs; Male; Tuberculosis | 1983 |
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1983 |
[Treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1982 |
[The effect of a combination of INH, Rifadin and Miambutol in generalized tuberculosis].
Topics: Animals; Drug Combinations; Ethambutol; Guinea Pigs; Isoniazid; Rifamycins; Tuberculosis | 1981 |
Ethambutol-induced thrombocytopenia.
Topics: Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Thrombocytopenia; Tuberculosis | 1982 |
[Clinically primary tuberculosis of the tongue].
Topics: Ethambutol; Humans; Isoniazid; Lung; Male; Middle Aged; Mouth Mucosa; Radiography; Rifampin; Tongue Diseases; Tuberculosis; Tuberculosis, Oral | 1982 |
Adverse drug reactions in TB therapy: risks and recommendations.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Evaluation; Ethambutol; Humans; Isoniazid; Kidney Diseases; Middle Aged; Optic Neuritis; Rifampin; Risk; Streptomycin; Tuberculosis | 1982 |
The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.
Topics: Adolescent; Adult; Ethambutol; Ethinyl Estradiol; Female; Humans; Isoniazid; Kinetics; Norethindrone; Norethindrone Acetate; Rifampin; Sex Hormone-Binding Globulin; Tuberculosis | 1980 |
[Ophthalmologic control examinations during therapy with ethambutol (author's transl)].
Topics: Aged; Ethambutol; Female; Humans; Middle Aged; Optic Atrophy; Optic Neuritis; Tuberculosis; Vision Disorders | 1981 |
Laryngeal tuberculosis: a hazard to the otolaryngologist.
Topics: Adult; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Laryngeal Neoplasms; Male; Middle Aged; Nurses; Occupational Diseases; Otolaryngology; Tuberculosis; Tuberculosis, Laryngeal | 1980 |
Current concept of short-term chemotherapy of tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1981 |
Tuberculosis in patients with end-stage renal disease.
Topics: Adult; Aged; Ethambutol; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin; Risk; Tuberculosis | 1980 |
Tuberculosis in the elderly: treating the "white plague".
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary; United States | 1980 |
Discoid lupus erythematosus and tuberculosis simulating systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Diagnosis, Differential; Ethambutol; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Male; Tuberculosis | 1980 |
A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Heroin Dependence; Hong Kong; Humans; Isoniazid; Male; Opioid-Related Disorders; Opium; Prisoners; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1980 |
Treatment of tuberculosis during pregnancy.
Topics: Ethambutol; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Tuberculosis | 1980 |
Tuberculosis of the breast.
Topics: Adult; Aged; Antitubercular Agents; Combined Modality Therapy; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy, Segmental; Mastitis; Middle Aged; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1995 |
Importance of surveillance mycobacterial cultures after liver transplantation.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Liver; Liver Transplantation; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Sputum; Streptomycin; Time Factors; Tuberculosis | 1995 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Impact of the change from an injectable to a fully oral regimen on patient adherence to ambulatory tuberculosis treatment in Dar es Salaam, Tanzania.
Topics: Administration, Oral; Ambulatory Care; Antitubercular Agents; Ethambutol; Humans; Injections, Intramuscular; Patient Compliance; Streptomycin; Tanzania; Tuberculosis | 1995 |
Ethambutol versus streptomycin during the hospitalized intensive phase of tuberculosis treatment in Benin.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Streptomycin; Tuberculosis | 1995 |
Drugs for tuberculosis.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Tuberculosis drug resistance in the Western Cape.
Topics: Adolescent; Adult; Aged; Drug Resistance, Multiple; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis | 1995 |
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Kenya; Male; Recurrence; Risk Factors; Thioacetazone; Tuberculosis | 1993 |
Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model.
Topics: Animals; Cells, Cultured; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Macrophages; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifabutin; Tuberculosis | 1995 |
Treating tuberculosis with one combination drug.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis | 1994 |
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fever; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 1994 |
Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.
Topics: Animals; Antibiotics, Antitubercular; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifamycins; Tuberculosis | 1994 |
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Monitoring; Ethambutol; Humans; Infant; Isoniazid; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
[Cephalosporins as possible methods of etiotropic therapy of tuberculosis].
Topics: Animals; Cefazolin; Cefotaxime; Cells, Cultured; Cephalosporins; Culture Media; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 1993 |
[Hepatic toxicity of antitubercular agents. Role of different drugs. 199 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1993 |
Turning intermittent regimens into daily regimens using blister-packs. An exploration in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Packaging; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Pyrazinamide; Rifampin; Tuberculosis | 1993 |
Treating multidrug-resistant tuberculosis: compliance and side effects.
Topics: Ethambutol; Humans; Optic Neuritis; Tuberculosis | 1994 |
From the Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
[Analysis of drug sensitivity of M. tuberculosis strains isolated from patients treated for tuberculosis in 1982-1991].
Topics: Adult; Child; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Species Specificity; Streptomycin; Tuberculosis | 1993 |
CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
Topics: Adult; Centers for Disease Control and Prevention, U.S.; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; United States | 1993 |
Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antitubercular Agents; Bisexuality; CD4-CD8 Ratio; Ethambutol; Female; HIV Seropositivity; Homosexuality; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Treatment Failure; Treatment Outcome; Tuberculosis | 1993 |
The high incidence of tuberculosis among renal transplant recipients in India.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; India; Isoniazid; Kidney Transplantation; Male; Pyrazinamide; Tuberculosis | 1996 |
Management of primary chest wall tuberculosis.
Topics: Abscess; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Combined Modality Therapy; Debridement; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Suppuration; Thoracic Diseases; Thoracic Neoplasms; Treatment Outcome; Tuberculosis | 1995 |
[Efficacy and tolerance of the treatment of tuberculosis in the aged].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; Risk Factors; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1996 |
Tuberculosis Control Programme Practical Guidelines, 1996--treatment regimens.
Topics: Antitubercular Agents; Ethambutol; Humans; Practice Guidelines as Topic; Pyrazinamide; Tuberculosis | 1996 |
Mycobacterial tenosynovitis of the flexor tendons of the hand. A report of five cases.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Carpal Tunnel Syndrome; Combined Modality Therapy; Ethambutol; Female; Hand; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Tenosynovitis; Tuberculosis | 1996 |
In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Isoniazid; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Rifamycins; Tuberculosis | 1996 |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Lung; Male; Mice; Mycobacterium avium Complex; Rifampin; Rifamycins; Spleen; Tuberculosis | 1996 |
Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Colony Count, Microbial; Drug Combinations; Ethambutol; Levofloxacin; Mice; Mycobacterium avium; Ofloxacin; Roxithromycin; Spleen; Tuberculosis | 1996 |
Focal tuberculosis of the liver with local hemorrhage in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ethambutol; Granuloma; Histocytochemistry; Homosexuality, Male; Humans; Isoniazid; Liver; Male; Mycobacterium; Pyrazinamide; Rifampin; Tuberculosis | 1996 |
Tuberculosis control programme guidelines--treatment regimens.
Topics: Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Optic Neuritis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; South Africa; Streptomycin; Tuberculosis | 1996 |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
Topics: Adult; Antibiotics, Antitubercular; Drug Interactions; Ethambutol; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Isoniazid; Liver Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Rifampin; Streptomycin; Tacrolimus; Tuberculosis | 1996 |
Tuberculosis and renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Kidney Transplantation; Male; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1996 |
Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California.
Topics: Adolescent; California; Cohort Studies; Disease Outbreaks; Drug Resistance, Multiple; Ethambutol; Ethionamide; Female; Humans; Infectious Disease Transmission, Vertical; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Schools; Skin Tests; Sputum; Streptomycin; Tuberculosis | 1997 |
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Coloring Agents; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Peru; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis; Xanthenes | 1998 |
Physician compliance with national tuberculosis treatment guidelines: a university hospital study.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitals, University; Humans; Isoniazid; Mycobacterium tuberculosis; Pakistan; Physicians; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Sputum; Surveys and Questionnaires; Tuberculosis; World Health Organization | 1998 |
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Ethambutol; Global Health; Humans; Isoniazid; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
Determination of ethambutol in plasma by high-performance liquid chromatography after pre-column derivatization.
Topics: Adult; Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Female; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis | 1998 |
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy.
Topics: Adolescent; Adult; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; BCG Vaccine; Cell Division; Cells, Cultured; Epitopes, T-Lymphocyte; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Lipoproteins; Male; Middle Aged; Mycobacterium tuberculosis; Peptides; Pleural Effusion; Pyrazinamide; Rifampin; T-Lymphocytes; Tuberculin; Tuberculosis | 1998 |
Tuberculosis of the pyriform fossa--a rare entity.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laryngoscopy; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Radiography; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Pulmonary | 1998 |
[Tuberculosis among hemodialysis patients in Dakar, apropos of 2 cases].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Hallucinations; Humans; Isoniazid; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Renal Dialysis; Rifampin; Senegal; Streptomycin; Tuberculosis | 1998 |
[Experimental study on the antituberculous activity of ofloxacins].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Ethambutol; Female; Male; Mice; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis | 1997 |
Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis | 1999 |
Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis | 1999 |
Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Streptomycin; Tuberculosis | 1999 |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Male; Mice; Mycobacterium avium; Tuberculosis | 1999 |
Unusual clinical manifestation of tuberculosis in a renal transplant recipient.
Topics: Adult; Antitubercular Agents; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Kidney Transplantation; Liver; Liver Function Tests; Postoperative Complications; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis | 1999 |
Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Liver; Liver Transplantation; Male; Middle Aged; Ofloxacin; Postoperative Complications; Retreatment; Treatment Outcome; Tuberculosis | 2000 |
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment].
Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Granuloma; HIV Infections; Humans; Lymphadenitis; Male; Mesentery; Mycobacterium avium; Peritoneal Diseases; Rifabutin; Time Factors; Tomography, X-Ray Computed; Tuberculosis | 2000 |
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Streptomycin; Tuberculosis | 2000 |
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Malawi; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2000 |
Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Wall; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2000 |
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 2000 |
Treatment of tuberculosis: a well-standardised protocol.
Topics: Adult; Child; Clinical Protocols; Ethambutol; France; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis; United Kingdom; United States; World Health Organization | 2000 |
Tuberculous abscess of the graft in a renal transplant recipient after chronic rejection: case report.
Topics: Abscess; Adult; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Graft Rejection; Humans; Isoniazid; Kidney Transplantation; Nephrectomy; Pyrazinamide; Reoperation; Rifampin; Tuberculosis | 2000 |
Tuberculosis after renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; India; Isoniazid; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Pyrazinamide; Pyridoxine; Retrospective Studies; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 2000 |
In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Tuberculosis | 2001 |
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Pyrazinamide; Rifampin; Saudi Arabia; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Effects of recombinant granulocyte-colony stimulating factor administration during Mycobacterium avium infection in mice.
Topics: Animals; Antimicrobial Cationic Peptides; Antitubercular Agents; Blood Proteins; Clarithromycin; Ethambutol; Female; Granulocyte Colony-Stimulating Factor; Interferon-gamma; Interleukin-10; Mice; Mice, Inbred C57BL; Mycobacterium avium; Neutrophils; Recombinant Proteins; Rifabutin; Tuberculosis | 2001 |
Treatment of tuberculosis in Haiti.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Haiti; Health Services Research; Humans; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2001 |
[Optic nerve neuropathy by ethambutol toxicity].
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Male; Optic Nerve; Optic Nerve Injuries; Treatment Outcome; Tuberculosis; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary; Vision Disorders | 1999 |
Tuberculosis presenting as immune thrombocytopenic purpura.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Autoimmune Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Middle Aged; Mycobacterium tuberculosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 2002 |
Sample survey of drug-resistant tuberculosis in Henan, China, 1996.
Topics: Adult; Aged; China; Data Collection; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2002 |
Tuberculosis of the pancreas diagnosed with needle aspiration.
Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Pancreas; Pancreatic Diseases; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2002 |
[Direct effect of ethambutol on acid formation and motor activity of the stomach in patients with tuberculosis].
Topics: Adolescent; Adult; Ethambutol; Female; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Peristalsis; Stomach; Tuberculosis | 1978 |
Tuberculosis in the 1980s: a case for short-course chemotherapy.
Topics: Animals; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Isoniazid; Mice; New Zealand; Pyrazinamide; Rifampin; Tuberculosis | 1979 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
The treatment of tuberculosis.
Topics: Aminosalicylic Acids; Capreomycin; Ethambutol; Ethionamide; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1975 |
Comparison of various measures of sensitivity of M. tuberculosis to ethambutol.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 1978 |
[The abdominal tuberculoses].
Topics: Aftercare; Cycloserine; Ethambutol; Ethionamide; Gastrointestinal Diseases; Humans; Mesentery; Peritoneum; Pyrazinamide; Tuberculosis; Tuberculosis, Gastrointestinal; Tuberculosis, Hepatic; Tuberculosis, Lymph Node | 1978 |
[Surveillance and complications of antituberculosis chemotherapy].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Hematologic Diseases; Humans; Isoniazid; Liver; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Rheumatic Diseases; Rifampin; Streptomycin; Tuberculosis | 1979 |
[Treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1978 |
[Tasks and possibilities in the near future of consultation bureaus for the prevention of tuberculosis].
Topics: Community Health Services; Ethambutol; History, 20th Century; Humans; Isoniazid; Netherlands; Rifampin; Transients and Migrants; Tuberculosis | 1978 |
Drug resistant tuberculosis in a large southern California hospital.
Topics: Aminosalicylic Acid; Antitubercular Agents; California; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mexico; Mycobacterium tuberculosis; Time Factors; Tuberculosis | 1977 |
[Tuberculosis in Romania (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Romania; Statistics as Topic; Tuberculosis | 1979 |
[Indications, dosage and combinations of the major antitubercular drugs].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1979 |
Tuberculosis and alcoholism. A partial solution through detection.
Topics: Alabama; Alcoholism; Ethambutol; Female; Humans; Isoniazid; Male; Mass Screening; Streptomycin; Tuberculosis | 1978 |
Clinical treatment of tuberculosis in rural Africa.
Topics: Ambulatory Care; Child; Democratic Republic of the Congo; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Medical Records; Rural Health; Streptomycin; Tuberculosis | 1978 |
Diseases of the respiratory system: tuberculosis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Streptomycin; Tuberculosis | 1978 |
Ethambutol and intra-ocular pressure.
Topics: Adult; Drinking; Ethambutol; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Tuberculosis | 1978 |
[An attempt to work out highly efficient short-course regimens by model experiments in mouse tuberculosis (author's transl)].
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Rifampin; Streptomycin; Tuberculosis | 1978 |
[Disturbances in the visual system caused by ethambutol (author's transl)].
Topics: Ethambutol; Humans; Optic Nerve; Optic Neuritis; Tuberculosis; Vision Disorders | 1978 |
Visual loss from ethambutol: clinical observations of seven patients.
Topics: Amblyopia; Ethambutol; Female; Humans; Male; Middle Aged; Tuberculosis | 1978 |
[4 cases of bilateral optic neuritis in the course of ethambutol treatment].
Topics: Adult; Aged; Ethambutol; Humans; Male; Middle Aged; Optic Neuritis; Tuberculosis | 1978 |
[Tuberculosis of hematopoietic organs in the child. 2 cases with pulmonary involvement].
Topics: Adolescent; Child, Preschool; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Prognosis; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1978 |
Treatment of tuberculosis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Costs and Cost Analysis; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Optic Neuritis; Pregnancy; Rifamycins; Tuberculosis | 1979 |
The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1975 |
[Characteristics of the action of ethambutol in experimental tuberculosis].
Topics: Animals; Dose-Response Relationship, Drug; Ethambutol; Guinea Pigs; Liver; Lung; Lymph Nodes; Mycobacterium tuberculosis; Spleen; Time Factors; Tuberculosis | 1976 |
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
Topics: Animals; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1976 |
Tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
[INH and rifampicin dosage at the beginning of tuberculosis treatment].
Topics: Drug Tolerance; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1977 |
[Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination (author's transl)].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Rifampin; Tuberculosis | 1977 |
[Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
Topics: Acetylation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Male; Optic Neuritis; Rifampin; Tuberculosis | 1977 |
Antituberculosis agents: isoniazid, rifampin, streptomycin, ethambutol.
Topics: Antibiotics, Antitubercular; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
Tuberculosis management in the mid-1970s.
Topics: Ambulatory Care; Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Self Medication; Sputum; Streptomycin; Time Factors; Tuberculosis; United States | 1976 |
[The results of liver biopsies during rifampicin therapy (author's transl)].
Topics: Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Humans; Liver; Male; Middle Aged; Rifampin; Tuberculosis | 1976 |
Orificial tuberculosis of the lip.
Topics: Adult; Biopsy; Ethambutol; Humans; Isoniazid; Lip Diseases; Male; Mouth Mucosa; Pyridoxine; Radiography; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Oral; Tuberculosis, Pulmonary | 1975 |
[Current aspects in treatment of tuberculosis].
Topics: Adult; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1976 |
[New aspects of tuberculosis therapy].
Topics: Contraceptives, Oral; Ethambutol; Female; Humans; Isoniazid; Menstruation; Methods; Pulmonary Heart Disease; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1975 |
[Ophthalmologic examinations in patients treated with ethambutol].
Topics: Adult; Color Perception; Ethambutol; Female; Humans; Optic Nerve; Tuberculosis; Vision Tests | 1975 |
[Does a correlation exist between Myambutol dosage and occurrence of optic neuritis].
Topics: Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Male; Optic Neuritis; Tuberculosis | 1975 |
Tuberculosis. Chemoprophylaxis and treatment.
Topics: Chemical and Drug Induced Liver Injury; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Streptomycin; Tuberculosis | 1975 |
[Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Rifampin; Sulfones; Tuberculosis | 1975 |
[Treatment of tuberculosis].
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1975 |
[Anti-Tuberculous therapy with rifampicin and ethambutol during pregnancy (author's transl)].
Topics: Abnormalities, Drug-Induced; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Tuberculosis | 1976 |
[Toxic effect of ethambutol on the eye organ].
Topics: Adolescent; Adult; Aged; Ethambutol; Eye Diseases; Female; Humans; Male; Middle Aged; Spondylitis; Tuberculosis | 1976 |
[Ocular toxicity of myambutol].
Topics: Aged; Dose-Response Relationship, Drug; Ethambutol; Eye; Eye Diseases; Humans; Middle Aged; Tuberculosis | 1976 |
Rationale for chemotherapy of tuberculosis and current recommendations.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1992 |
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Glucocorticoids; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium; Quinolones; Receptors, Glucocorticoid; Spleen; Time Factors; Tuberculosis | 1992 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
Ethambutol in tuberculosis.
Topics: Blindness; Ethambutol; Humans; Optic Neuritis; Tuberculosis; Visual Pathways | 1990 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Clinical application of the polymerase chain reaction for a rapid diagnosis of Mycobacterium tuberculosis infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Base Sequence; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Molecular Sequence Data; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis | 1992 |
Tuberculosis of the oesophagus.
Topics: Aged; Deglutition Disorders; Drug Therapy, Combination; Esophageal Diseases; Ethambutol; Female; Follow-Up Studies; Humans; Time Factors; Tuberculosis | 1992 |
[Cold tuberculous retropharyngeal abscess].
Topics: Abscess; Brachial Plexus Neuritis; Deglutition Disorders; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Neck; Rifampin; Tuberculosis | 1992 |
Pancreatic tuberculosis following renal transplantation.
Topics: Ethambutol; Female; Humans; Immunosuppression Therapy; Isoniazid; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pancreatic Diseases; Postoperative Complications; Rifampin; Transplantation, Homologous; Tuberculosis | 1992 |
Tuberculosis in the 1990's: resurgence, regimens, and resources.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Child; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; False Negative Reactions; Humans; Isoniazid; Pyrazinamide; Radiography, Thoracic; Rifampin; Risk Factors; Streptomycin; Tuberculosis; United States | 1992 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement.
Topics: Black or African American; Black People; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; South Africa; Streptomycin; Tuberculosis | 1992 |
Mycobacterium bovis (BCG) vaccination. Progressive disease in a patient asymptomatically infected with the human immunodeficiency virus.
Topics: Adult; BCG Vaccine; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Mycobacterium bovis; Rifampin; Tuberculosis | 1992 |
AIDS and tuberculosis in Spain. A report of 140 cases.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Prospective Studies; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Substance Abuse, Intravenous; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
[Tuberculosis of the larynx, oral cavity and pharynx].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy; Ethambutol; Humans; Isoniazid; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Oral | 1991 |
Contribution of pyrazinamide to antituberculosis chemotherapy.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Pyrazinamide; Tuberculosis | 1991 |
Ocular toxicity of ethambutol.
Topics: Ethambutol; Humans; Tuberculosis; Vision Disorders; Visual Acuity | 1991 |
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
[Drug therapy of intractable Mycobacterium infections].
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis | 1990 |
[Tuberculosis: a disease that is difficult to eradicate. Description of a case].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Lymph Node | 1990 |
Cost savings from alternative treatments for tuberculosis.
Topics: Ambulatory Care; Antitubercular Agents; Botswana; Cost-Benefit Analysis; Ethambutol; Humans; Isoniazid; Patient Compliance; Retrospective Studies; Rifampin; Thioacetazone; Tuberculosis | 1986 |
Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis | 1989 |
Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
Topics: Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Libya; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1989 |
[Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
[Routine use of 6-month antitubercular treatment in 300 patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1986 |
Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections.
Topics: Animals; Chronic Disease; Clofazimine; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifabutin; Rifamycins; Tuberculosis | 1987 |
Drug-resistant tuberculosis in Sierra Leone.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sierra Leone; Streptomycin; Tuberculosis | 1986 |
Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan.
Topics: Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Osmolar Concentration; Rifampin; Streptomycin; Tuberculosis; United States | 1988 |
[Toxic optic neuritis with ethambutol].
Topics: Adult; Aged; Ethambutol; Female; Humans; Male; Middle Aged; Optic Neuritis; Tuberculosis | 1988 |
Multidrug chemotherapy of tuberculosis in rhesus monkeys.
Topics: Animals; Antitubercular Agents; Disease Outbreaks; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Macaca; Macaca mulatta; Male; Monkey Diseases; Mycobacterium bovis; Radiography; Rifampin; Tuberculosis | 1988 |
Drugs for tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 1988 |
American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children.
Topics: Adult; Age Factors; Blood Cell Count; Blood Urea Nitrogen; Child; Creatinine; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lactation; Liver; Mycobacterium bovis; Pregnancy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculin; Tuberculosis | 1986 |
[Basic experiment on the action of isobutol in tuberculosis].
Topics: Animals; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Isoniazid; Male; Mice; Microbial Sensitivity Tests; Tuberculosis | 1986 |
Antituberculous agents.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1987 |
Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Tuberculosis | 1986 |
The effect of ethambutol on tubercle bacilli within cultured human macrophages.
Topics: Adult; Cells, Cultured; Ethambutol; Female; Humans; Macrophages; Male; Middle Aged; Mycobacterium tuberculosis; Time Factors; Tuberculosis | 1985 |
Tuberculosis control practices in major metropolitan health departments in the United States. 3. Standard of practice in 1984.
Topics: Adolescent; Adult; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Health Facilities; Health Policy; Health Surveys; Humans; Isoniazid; Public Health Administration; Rifampin; Tuberculosis; United States | 1985 |
Successful treatment of tuberculous brain abscess.
Topics: Brain Abscess; Ethambutol; Humans; Male; Middle Aged; Pyrazinamide; Tomography, X-Ray Computed; Tuberculosis | 1985 |
Clinical experience with short-course chemotherapy in patients with tubercular pleural effusion and lymphadenitis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymphadenitis; Male; Middle Aged; Pleural Effusion; Rifampin; Time Factors; Tuberculosis | 1985 |
The choice of systemic antimicrobial drugs.
Topics: Ampicillin; Anti-Infective Agents; Carbenicillin; Ethambutol; Gentamicins; Humans; Infant; Infant, Newborn; Injections, Intravenous; Injections, Spinal; Isoniazid; Meningitis; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Sepsis; Staining and Labeling; Tuberculosis; Urinary Tract Infections | 1971 |
[Recent developments in the treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1972 |
New drugs in tuberculosis.
Topics: Capreomycin; Chemical and Drug Induced Liver Injury; Drug Combinations; Ethambutol; Gastrointestinal Diseases; Rifampin; Tuberculosis | 1971 |
[Use of Mycobacterium phlei of differentiated resistance for the detection of ethambutol and capreomycin in the sera of tuberculous patients].
Topics: Capreomycin; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Tuberculosis | 1972 |
[Distribution of variants resistant to ethambutol or to capreomycine in wild strains of Mycobacterium tuberculosis].
Topics: Capreomycin; Drug Resistance, Microbial; Ethambutol; Genetic Variation; Mycobacterium tuberculosis; Tuberculosis | 1972 |
[Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Ethambutol; Ethionamide; Finland; Humans; Isoniazid; Patient Dropouts; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Binding of rifampicin by human plasma proteins.
Topics: Adult; Aged; Aminosalicylic Acids; Blood Proteins; Carbon Radioisotopes; Chromatography, Thin Layer; Dialysis; Ethambutol; Female; Fibrinogen; gamma-Globulins; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Rifampin; Serum Albumin; Streptomycin; Tuberculosis | 1974 |
Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
Topics: Capreomycin; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Mycobacterium tuberculosis; Paromomycin; Rifampin; Sulfisoxazole; Tuberculosis; Viomycin | 1974 |
In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; In Vitro Techniques; Isoniazid; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1968 |
Drugs for tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1968 |
In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; In Vitro Techniques; Isoniazid; Methods; Phenylthiourea; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis | 1968 |
The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
Topics: Animals; Ethambutol; Ethionamide; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1969 |
A survey of mycobacterial isolates from the Randwick Chest Hospital, Sydney, in an 18-month period, 1970 to 1971.
Topics: Adult; Aged; Aminosalicylic Acids; Australia; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1973 |
Endobronchial tuberculosis.
Topics: Aged; Bronchial Diseases; Bronchoscopy; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Tracheal Diseases; Tuberculosis | 1973 |
[Results of daily-oral therapy with ethambutol and isoniazid in tuberculosis (author's transl)].
Topics: Administration, Oral; Adolescent; Adult; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Long-Term Care; Middle Aged; Sputum; Tuberculosis | 1973 |
Tuberculosis in Acukland.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Mycobacterium tuberculosis; New Zealand; Rifampin; Sex Factors; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
Ethambutol. Synthesis of an unsaturated analog.
Topics: Animals; Ethambutol; Mice; Mycobacterium tuberculosis; Optical Rotation; Tuberculosis | 1974 |
[Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
Topics: Adaptation, Physiological; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Long-Term Care; Rifampin; Streptomycin; Transaminases; Tuberculosis | 1974 |
Primary drug-resistant Mycobacterium tuberculosis isolated in Massachusetts in 1972.
Topics: Adolescent; Adult; Aged; Alcoholism; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Massachusetts; Middle Aged; Mycobacterium tuberculosis; Streptomycin; Substance-Related Disorders; Tuberculosis | 1974 |
[Algodystrophy associated with antitubercular chemotherapy: 22 cases].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Niacinamide; Pyrazinamide; Reflex Sympathetic Dystrophy; Rifampin; Tuberculosis; Vitamin B Deficiency | 1969 |
[Ocular toxicity of ethambutol].
Topics: Adolescent; Adult; Aged; Child; Color Perception; Color Perception Tests; Ethambutol; Eye; Female; Humans; Isomerism; Male; Middle Aged; Optic Neuritis; Tuberculosis; Vision Disorders; Visual Acuity; Visual Fields | 1971 |
[Effect of schizophyllan in experimental tuberculosis].
Topics: Animals; Antitubercular Agents; Basidiomycota; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethambutol; Glycosaminoglycans; Liver; Lung; Lymph Nodes; Male; Mice; Polysaccharides; Rifampin; Spleen; Streptomycin; Tuberculosis | 1973 |
[Facial paralysis caused by tubercular otitis. Current therapeutic possibilities].
Topics: Adult; Ethambutol; Facial Paralysis; Female; Humans; Isoniazid; Male; Otitis; Rifampin; Tuberculosis | 1974 |
Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Isoniazid; Kanamycin; Mice; Phenylthiourea; Streptomycin; Tuberculosis; Viomycin | 1967 |
[Treatment with new antitubercular agents].
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis; Viomycin | 1968 |
[Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1969 |
[How to oversee the treatment of tuberculosis?].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Long-Term Care; Male; Medication Errors; Middle Aged; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Injections, Intravenous; Isoniazid; Kanamycin; Mice; Mycobacterium tuberculosis; Phenylthiourea; Streptomycin; Tuberculosis; Viomycin | 1970 |
[Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitubercular Agents; Body Weight; Ethambutol; Ethionamide; Injections, Intramuscular; Kanamycin; Lung; Mice; Organ Size; Pyrazinamide; Rifampin; Spleen; Tuberculosis; Viomycin | 1971 |
[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
Twice weekly tuberculosis chemotherapy.
Topics: Absenteeism; Administration, Oral; Adult; Aged; Colorado; Community Health Services; Ethambutol; Evaluation Studies as Topic; Female; Follow-Up Studies; Hospitalization; Humans; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Pyridoxine; Streptomycin; Tuberculosis; Viomycin | 1973 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
[Analysis of toxicity in intermittent ethambutol-medication (author's transl)].
Topics: Adult; Ethambutol; Female; Humans; Optic Nerve; Peripheral Nervous System Diseases; Retinal Diseases; Tuberculosis | 1973 |
[Cold thoracic abscess due to Histoplasma duboisii. Treatment using rifampicin].
Topics: Abscess; Adult; Diagnosis, Differential; Ethambutol; Fluorescent Antibody Technique; Histoplasma; Histoplasmosis; Humans; Isoniazid; Male; Rifampin; Skin Tests; Thorax; Tuberculosis | 1973 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[The liver and rifampicin].
Topics: Bilirubin; Biopsy; Chemical and Drug Induced Liver Injury; Drug Interactions; Ethambutol; Humans; Isoniazid; Liver; Phosphoric Monoester Hydrolases; Rifampin; Transaminases; Tuberculosis | 1973 |
[Ocular damage due to myambutol (ethambutol) (author's transl)].
Topics: Aged; Ethambutol; Eye Diseases; Female; Humans; Male; Middle Aged; Optic Nerve; Retinal Hemorrhage; Retinitis; Scotoma; Tuberculosis | 1974 |
[Survey of the tuberculosis problem in the Nordic countries. Are BCG vaccination and mass screening necessary?].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; BCG Vaccine; Ethambutol; Female; Humans; Iceland; Infant, Newborn; Isoniazid; Male; Mass Chest X-Ray; Middle Aged; Registries; Retrospective Studies; Rifampin; Scandinavian and Nordic Countries; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1974 |
Intermittent chemotherapy for adults with tuberculosis.
Topics: Administration, Oral; Adult; Drug Resistance, Microbial; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1974 |
[The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
Topics: Administration, Oral; Adult; Antitubercular Agents; Digitoxin; Drug Therapy, Combination; Ethambutol; Humans; Hydroxylation; Intestinal Absorption; Isoniazid; Kidney Tubules; Kinetics; Liver; Middle Aged; Protein Binding; Radioimmunoassay; Rifampin; Tuberculosis | 1974 |
[Hematopoietic tuberculosis].
Topics: Bone Marrow; Bone Marrow Examination; Cholestasis; Erythema; Ethambutol; Humans; Isoniazid; Leukopenia; Male; Middle Aged; Neutropenia; Peritonitis, Tuberculous; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Osteoarticular; Tuberculosis, Splenic; Vitamin B Complex | 1974 |
[Side effects of ethambutol in clinical observation].
Topics: Adolescent; Adult; Aged; Ethambutol; Eye; Female; Humans; Male; Middle Aged; Tuberculosis | 1974 |
[Ocular toxicity of Myambutol (author's transl)].
Topics: Age Factors; Aged; Ethambutol; Female; Humans; Middle Aged; Optic Nerve; Retina; Tuberculosis | 1974 |
Experiences with rifampicin.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Tuberculosis | 1974 |
The impact of rifampicin on the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1974 |
Experiences with rifampicin.
Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Tuberculosis | 1974 |
Drugs used in the management of tuberculosis. IV. Secondary tuberculostatic agents.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Rifampin; Tuberculosis | 1973 |
[Optic neuritis and ethambutol. 6 new cases].
Topics: Color Vision Defects; Electroretinography; Ethambutol; Female; Fundus Oculi; Humans; Male; Optic Neuritis; Remission, Spontaneous; Scotoma; Tuberculosis; Vasodilator Agents; Visual Acuity; Vitamin B Complex | 1973 |
[Critical concentration for definition of rifampicin resistance of tubercle bacilli].
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1972 |
Undiagnosed tuberculosis in a general hospital.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Biopsy; Body Weight; Bone Marrow; Ethambutol; Fatigue; Female; Hospitals, General; Humans; Isoniazid; Liver; Male; Middle Aged; Mycobacterium tuberculosis; Radiography; Spleen; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1972 |
An epidemiologic account of tuberculosis transmitted from man to monkey.
Topics: Adult; Animals; Cross Infection; Ethambutol; Female; Haplorhini; Humans; Isoniazid; Macaca; Male; Pyridoxine; Radiography; Skin Tests; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis | 1972 |
[Treatment of tuberculosis in childhood].
Topics: Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1972 |
[Modern view on drug therapy of tuberculosis].
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1972 |
The Australian rifampicin trial.
Topics: Adult; Aged; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1972 |
[Modification of the classical chemotherapy by the use of ethambutol].
Topics: Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Methods; Middle Aged; Streptomycin; Tuberculosis | 1972 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1972 |
[Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
Topics: Animals; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Methods; Rifampin; Tuberculosis | 1973 |
[Ethambutol excretion in tuberculous patients with moderately impaired renal function].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Kidney; Male; Middle Aged; Tuberculosis | 1973 |
[Myambutol blood level in continous medication].
Topics: Ethambutol; Humans; Tuberculosis | 1973 |
[Antitubercular activity and concentrations of rifampicin and ethambutol in the organs].
Topics: Animals; Disease Models, Animal; Ethambutol; Mice; Rifampin; Tuberculosis | 1973 |
[Rifampicin in the treatment of tuberculosis].
Topics: Administration, Oral; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1973 |
[Damage to the organ of vision following ethambutol treatment].
Topics: Aged; Color Perception; Ethambutol; Female; Humans; Male; Middle Aged; Optic Nerve; Tuberculosis | 1973 |
Mycobacterium marinum (atypical acid-fast bacillus) infections of the hand.
Topics: Adolescent; Adult; Amputation, Surgical; Debridement; Diagnosis, Differential; Ethambutol; Female; Fingers; Hand; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Osteomyelitis; Rifampin; Skin Diseases, Infectious; Skin Ulcer; Synovitis; Tuberculosis | 1973 |
Pilocarpine hydrolysis: clinical significance.
Topics: Adult; Aged; Animals; Ethambutol; Glaucoma; Humans; Hydrolases; Hydrolysis; In Vitro Techniques; Injections, Subcutaneous; Intraocular Pressure; Middle Aged; Ophthalmic Solutions; Pilocarpine; Rabbits; Time Factors; Tuberculosis | 1973 |
[Modern treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Recurrence; Rifampin; Streptomycin; Sweden; Tuberculosis | 1973 |
[Minimum daily efficient dose of ethambutol: general review].
Topics: Ethambutol; Humans; Tuberculosis | 1973 |
Editorial: Rifampin in the treatment of tuberculosis.
Topics: Canada; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1974 |
Hyperuricemia induced by ethambutol.
Topics: Allopurinol; Creatinine; Diuretics; Ethambutol; Ethanol; Gout; Humans; Isoniazid; Lactates; Pyrazinamide; Pyridoxine; Salicylates; Stimulation, Chemical; Streptomycin; Time Factors; Tuberculosis; Uric Acid | 1974 |
Mycobacterium tuberculosis infection of the middle ear.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Otitis Media; Pyridoxine; Rifampin; Tuberculosis; Tuberculosis, Meningeal | 1974 |
[Ethambutol induced severe optic neuritis].
Topics: Adult; Aged; Chelating Agents; Drug Interactions; Electroretinography; Ethambutol; Ethanol; Evoked Potentials; Female; Humans; Isoniazid; Male; Middle Aged; Nephrectomy; Nicotine; Optic Nerve; Optic Neuritis; Scotoma; Tuberculosis; Visual Acuity; Visual Fields; Zinc | 1974 |
[Treatment of primary tuberculosis].
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Antibody Formation; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunity, Cellular; Infant; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1974 |
Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Streptomyces; Streptomycin; Tuberculosis | 1969 |
Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.
Topics: Animals; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Spleen; Time Factors; Tuberculosis | 1968 |
[Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Germany, West; Hospitals, Convalescent; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1969 |
Sensitivity test and side effects of ethambutol.
Topics: Adult; Drug Resistance, Microbial; Ethambutol; Exanthema; Eye Diseases; Female; Humans; Male; Menstruation Disturbances; Mycobacterium tuberculosis; Tuberculosis | 1968 |
Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
Topics: Animals; Ethambutol; Ethionamide; Follow-Up Studies; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Spleen; Streptomycin; Tuberculosis | 1969 |
[Antitubercular effect of ethambutol in vitro].
Topics: Antitubercular Agents; Clinical Laboratory Techniques; Diffusion; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Tuberculosis | 1969 |
[Results of treatment of experimental tuberculosis in guinea pigs with isoniazid or with isoniazid combined with ethambutol, either in continous or in intermittent regimen].
Topics: Animals; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Fatty Liver; Guinea Pigs; Isoniazid; Liver; Lung; Mycobacterium tuberculosis; Tuberculosis | 1970 |
Third Annual Australian Tuberculosis Conference.
Topics: Australia; Ethambutol; Humans; Mycobacterium tuberculosis; Pneumoconiosis; Tuberculosis; Zimbabwe | 1969 |
[Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Time Factors; Tuberculosis | 1970 |
[Current state of primary tuberculosis in children in Rhone department].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; France; Humans; Infant; Mycobacterium tuberculosis; Radiography; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
Topics: Animals; Cycloserine; Drug Resistance, Microbial; Endopeptidases; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mice; Mycobacterium tuberculosis; Streptomycin; Sulfamethoxypyridazine; Tuberculosis | 1970 |
[Report on the scientific and didactic activity of the Phtisiologic Clinic of the University of Rome, of the Center of Studies of the Sanatorium-Hospital Carlo Forlanini of the I.N.P.S. in the course of 1966].
Topics: Adult; Ethambutol; Gastrectomy; Humans; Italy; Lung Diseases; Lung Neoplasms; Mycobacterium tuberculosis; Sex Factors; Tuberculosis; Tuberculosis, Pulmonary | 1967 |
[Activity of rifampicin on experimental tuberculosis in mice. The development of resistance to rifampicin. Therapeutic effects of combinations of different drugs with rifampicin].
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1970 |
Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
Topics: Administration, Oral; Adolescent; Adult; Aminosalicylic Acids; Animals; Culture Media; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Guinea Pigs; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Organ Size; Rifampin; Spleen; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred Strains; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis | 1971 |
Mode of action of antituberculous agents and ultrastructure of mycobacteria.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Isoniazid; Kanamycin; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1971 |
[On higher incidence of epileptic seizures during ethambutol treatment].
Topics: Adolescent; Adult; Epilepsy; Ethambutol; Female; Humans; Tuberculosis | 1972 |
[Toxic damage of the optic nerve by Myambutol].
Topics: Aged; Color Perception Tests; Ethambutol; Humans; Male; Middle Aged; Optic Atrophy; Scotoma; Tuberculosis; Visual Fields | 1972 |
[Eye complications following ethambutol therapy].
Topics: Aged; Color Perception; Ethambutol; Eye; Female; Humans; Male; Middle Aged; Tuberculosis | 1972 |
[Experience with the use of ethambutol in tuberculosis].
Topics: Adult; Ethambutol; Female; Humans; Tuberculosis | 1971 |
[Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Spleen; Streptomycin; Sulfonamides; Tuberculosis | 1971 |
[Ethambutol].
Topics: Ethambutol; Humans; Optic Neuritis; Tuberculosis | 1971 |
[Dynamics of experimental tuberculous lesions in guinea pigs under the influence of ethambutol therapy].
Topics: Animals; Ethambutol; Guinea Pigs; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1971 |
[Our experience with Rifampicin].
Topics: Ethambutol; Female; Humans; Male; Rifampin; Tuberculosis; Tuberculosis, Meningeal | 1971 |
Problems of drug resistance in tuberculosis--the newer anti-tuberculosis drugs.
Topics: Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Tuberculosis; United Kingdom; United States | 1971 |
Metabolic and special studies of ethambutol in normal volunteers and tuberculous patients.
Topics: Adult; Aged; Antitubercular Agents; Blindness; Blood; Copper; Ethambutol; Female; Humans; In Vitro Techniques; Male; Middle Aged; Mortality; Pregnancy; Tuberculosis; Vision, Ocular; Zinc | 1966 |
Ethambutol in the retreatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Blood; Ethambutol; Female; Humans; Male; Middle Aged; Radiography, Thoracic; Tuberculosis; Uric Acid; Vision, Ocular | 1966 |
Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.
Topics: Antitubercular Agents; Cycloserine; Ethambutol; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium Infections; Tuberculosis; Vision, Ocular | 1966 |
Clinical activity of cycloserine in the treatment of tuberculosis.
Topics: Adult; Aged; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Middle Aged; Pyrazinamide; Tuberculosis | 1970 |
Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Male; Mice; Mycobacterium; Pyrazinamide; Streptomycin; Tuberculosis | 1967 |
An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
Topics: Administration, Oral; Animals; Drug Synergism; Ethambutol; Ethionamide; Female; Isoniazid; Mice; Mice, Inbred Strains; Rifampin; Tuberculosis | 1971 |
Rifampicin.
Topics: Bronchitis; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Economics, Medical; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1969 |
[Comparison of suitableness of H37RV strain and Mycobacterium phlei for determination of serum levels of ethambutol and capreomycin].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Mycobacterium; Tuberculosis | 1969 |
[Resistance to ethambutol and capreomycine in experimental tuberculosis in guinea pigs].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Guinea Pigs; Tuberculosis | 1969 |
[Report from the scientific conference on the treatment with ethambutol and capreomycine].
Topics: Antitubercular Agents; Ethambutol; Humans; Poland; Tuberculosis | 1969 |
[Eye examinations during treatment with the new tuberculostatic ethambutol-dihydrochloride Lederle (Myambutol)].
Topics: Adult; Ethambutol; Female; Humans; Male; Middle Aged; Ophthalmoscopy; Optic Neuritis; Tuberculosis; Vision Disorders; Vision Tests | 1969 |
[Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
Topics: Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tooth Diseases; Tuberculosis; Tuberculosis, Pulmonary | 1969 |
[Treatment of resistant chronic tuberculosis. A new antitubercular agent: terizidone].
Topics: Adult; Alcoholism; Cycloserine; Ethambutol; Humans; Male; Middle Aged; Pyrazines; Tuberculosis | 1969 |
[Antitubercular chemotherapy and the progress realized by various new drugs].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Middle Aged; Pyrazines; Rifampin; Tuberculosis | 1969 |
[Results of systematic exploration of the visual function in patients treated with ethambutol].
Topics: Amblyopia; Ethambutol; Eye Diseases; Humans; Tuberculosis | 1969 |
[Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
A study of ethambutol as a supplement to standard triple-drug regimen.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Sputum; Streptomycin; Tuberculosis | 1970 |
[Current views on drug treatment of tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Rifampin; Tuberculosis | 1970 |
Resistance of tubercle bacilli to ethambutol and capreomycin in experimental tuberculosis of guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Ethambutol; Guinea Pigs; Tuberculin Test; Tuberculosis | 1970 |
The action of rifampin alone and in combination with other antituberculous drugs.
Topics: Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Modern chemotherapy of tuberculosis].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Berlin; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Infant; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis | 1970 |
[New drugs in the treatment of primary tuberculosis].
Topics: Aminosalicylic Acids; Child; Child, Preschool; Ethambutol; Female; France; Humans; Isoniazid; Male; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[Current views on drug treatment of tuberculosis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1970 |
[A new and powerful anti-tubercular drug: rifampicin].
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Infusions, Parenteral; Isoniazid; Rifampin; Streptomyces; Tuberculosis | 1970 |
[A new and powerful anti-tubercular drug: rifampicin].
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Infusions, Parenteral; Isoniazid; Rifampin; Streptomyces; Tuberculosis | 1970 |
The undesired side-effects of Myambutol.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Male; Middle Aged; Time Factors; Tuberculosis; Vision Disorders; Vision Tests | 1970 |
Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
Topics: Administration, Oral; Animals; Drug Combinations; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Mice; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
Consequences of the development of new antituberculous drugs for the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Local treatment of pulmonary and extrapulmonary tuberculosis with ethambutol].
Topics: Adult; Antitubercular Agents; Bronchial Diseases; Ethambutol; Female; Humans; Male; Middle Aged; Pleurisy; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1970 |
Experimental therapy with rifampicin.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Mice; Mycobacterium Infections; Phenylthiourea; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
[Standard therapy of tuberculosis].
Topics: Antitubercular Agents; Body Weight; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1971 |
[Symposium: chemotherapy including new antitubercular agents].
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1971 |
[Changing picture of tuberculosis during a decade].
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
Topics: Animals; Cell Count; Chronic Disease; Disease Models, Animal; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Lung; Mice; Placebos; Rifampin; Streptomycin; Tuberculosis | 1971 |
[The rational basis for the treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis | 1971 |
[Dissolved tuberculostatics. A safe intake method during hospitalization].
Topics: Administration, Oral; Ethambutol; Hospitalization; Humans; Isonicotinic Acids; Solutions; Tuberculosis | 1971 |
"Control of tuberculosis" up-to-date.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1971 |
[Experimental study of rifampicin and ethambutol].
Topics: Animals; Blood Bactericidal Activity; Ethambutol; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Mice; Microbial Sensitivity Tests; Rabbits; Rifampin; Tuberculosis | 1971 |
Ethambutol in the treatment of tuberculosis. A statement by the committee on therapy.
Topics: Ethambutol; Humans; Tuberculosis | 1968 |
Anti-tuberculosis chemotherapy in Australia.
Topics: Australia; Ethambutol; Humans; Tuberculosis; Vision Disorders; Visual Acuity | 1968 |
[Chemotherapy of tuberculosis today with special consideration of capreomycin, ethambutol and rifampicin].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Tuberculosis | 1968 |
[Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
Topics: Animals; Body Weight; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Rifampin; Tuberculosis | 1968 |
[Intermittent ethambutol therapy of experimental tuberculosis in guinea pigs].
Topics: Animals; Body Weight; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Tuberculosis | 1968 |
Chemotherapy of drug-resistant tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
New drugs active against tuberculosis.
Topics: Animals; Ethambutol; Female; Humans; Mice; Rifampin; Tuberculosis | 1969 |
Ethambutol.
Topics: Antitubercular Agents; Ethambutol; Eye; Humans; Tuberculosis | 1966 |
[Behavior of the ocular apparatus in subjects treated with a new synthetic antitubercular drug (E.M.B.). (Clinical research)].
Topics: Adolescent; Adult; Aged; Choroiditis; Ethambutol; Female; Humans; Male; Middle Aged; Optic Neuritis; Tuberculosis; Vision Disorders | 1966 |